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ABSTRACT
Acute lower respiratory infections (pneumonia) and pneumonia-derived sepsis are among the
leading causes of death in the world causing 7.8 million deaths annually. In this regard,
Methicillin-resistant Staphylococcus aureus (MRSA) is endemic in the US and implicated for
causing high mortality-associated necrotizing pneumonia and aggravating viral pneumonia with
superinfection. Additionally, sepsis is the 7th leading cause of death among newborns in the US
and is responsible for more than 750,000 hospitalization cases every year. Although there is a
plethora of research in both pneumonia and sepsis, the detailed pathophysiology still remains
elusive. Understanding the host defense mechanism will help designing better therapeutic
interventions to treat such infections.
In this context, NLRP6 is a member of Nod-like receptor (NLR) family that has been
proposed to regulate microbiota, gut-epithelial integrity, and host defense against Listeria
infections. While NLRP6 is expressed in lungs, liver, spleen, and kidneys, its role in sepsis and
MRSA-induced pneumonia remains unexplored. Neutrophils play critical role to limit the
Staphylococcal infection; however how neutrophils homeostasis is orchestrated during
pulmonary MRSA infection remains elusive. Using NLRP6 gene-deficient mice, we demonstrate
that NLRP6 negatively regulates Gram-positive bacteria-induced pneumonia via regulating
phagocytic oxidase activity and cell death mechanism of neutrophils. NLRP6 triggers
necroptosis and pyroptosis that reduces phagocytic cells in the lungs. In addition, in a murine
model of CLP-induced polymicrobial sepsis, we found that NLRP6 is detrimental for
lymphocyte survival and function in the spleen. Furthermore, our data illustrate that MRSA
upregulates CXCL5 in order to suppress granulopoiesis and neutrophil trafficking from bone
marrow to the lungs.
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In conclusion, MRSA exploits CXCL5 to suppress the neutrophil accumulation in the
lungs as an immune evasion strategy. NLRP6 inflammasome is detrimental during MRSAinduced pneumonia and polymicrobial sepsis. Blocking of NLRP6 could be an effective
therapeutic strategy to treat both septic and MRSA-infected patients.
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CHAPTER 1. NLRP6 INFLAMMASOME IN HEALTH AND DISEASES
1.1 Introduction
The mammalian immune system is endowed with the germline-encoded pattern
recognition receptors (PRR) that sense both pathogen-associated molecular patterns (PAMPs)
and damage-associated molecular patterns (DAMPs) to initiate proinflammatory responses as a
first line of defense. PRRs can be classified into two groups based on their cellular localization.
The first group includes Toll-like receptors (TLRs) and C-type lectin (CTL) receptors that
surveil the extracellular and endosomal compartments. The second class of PRRs includes
Retinoic acid-inducible gene (RIG)-like receptors (RLRs) and nucleotide-oligomerization
domain (NOD) like receptors (NLRs), which survey intracellular compartments for the presence
of PAMPs and DAMPs [1]. Thus far, 23 NLRs have been identified in humans and more than 30
have been identified in mice [2]; however, only a few of these have been extensively studied.
Predominantly expressed in first responder cells like neutrophils, macrophages and dendritic
cells, NLRs are multi-domain protein complexes consisting of a central nucleotide
oligomerization domain (NOD or NACHT) flanked by C-terminal leucine-rich repeats (LRRs)
for sensing PAMPs and DAMPs, and a variable N-terminal region consisting of either a caspase
activation and recruitment domain (CARD), pyrin domain (PYD), or baculovirus inhibitor
repeats (BIR) [2-7]. Unlike other classes of receptors, NLRs are unique in the sense that many of
them can form a supramolecular complex, known as an inflammasome, by recruiting apoptosisassociated speck-like protein (ASC) and caspase-1 or 11 after sensing PAMPs or DAMPs. The
activated caspase converts the inactive forms of IL-1β and IL-18 into their respective active
forms to initiate inflammatory signaling [8, 9]. Based on the phylogenetic structure of the central
NACHT domain, NLRs can be classified into three broad categories: NODs, NLRPs or NALPs
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(NLRP1-14), and the IPAF family of NLRs [NLRC4 and NLR family apoptosis inhibitory
proteins (NAIPs)] [3] (Fig. 1.1).

Figure 1.1 Different inflammasomes and their domain organization. Based on the structure of
central NACHT domain, NLRs can be classified into three broad categories: the NODs (NOD1,
NOD2, NOD3, NOD4, NOD5, and CIITA), the NLRPs or NALPs (NLRP1-14), and the IPAF
family of NLRs [NLRC4 and NLR family apoptosis inhibitory proteins (NAIPs)]. NOD1 and
NOD2 contains CARD, NBD, and LRR domain whereas NOD3-5 and CIITA lacks card domain.
In addition to NBD and LRR, NAIPs contain BIR domain whereas IPAF contains CARD instead
of BIR. NLRP10 only contain PYD and NBD whereas NLRP2-9 and NLRP11-14 contain PYD,
NBD, and LRR. Interestingly, NLRP1 has FIIND and CARD domains in addition to PYD, NBD,
and LRR [3, 10]. . ASC consists of PYD and CARD domains and caspase 1/11 have CARD,
p10, p20 fragments. CIITA: class II transactivator; FIIND: function to find domain; NBD:
nucleotide-binding domain, PYD: pyrin domain, LRR: leucine-rich repeats, CARD: caspase
activation and recruitment domain, and BIR: baculovirus inhibitor of apoptosis protein repeat.
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Because NLRP6 is a relatively new member of the NLR family its detailed signaling
mechanism is yet to be established. During its initial identification, NLRP6 was shown to
activate caspase-1, like other NLRs, and NF-kB, like TLRs, suggesting that it is unique in the
NLR family as it can perform functions of both NLRs and TLRs [11]. This notion is supported
by other studies demonstrating a wide scope of physiological functions of NLRP6 ranging from
modulation of the host-microbial interface [12] and host defense against pathogens [13, 14] to
inhibition of carcinogenesis [15] and neuroinflammation [16]. However, NLRP6 has also been
shown to negatively regulate NF-κB signaling in mouse model [14]. In this review, we discuss
the recent advancements in understanding of NLRP6 inflammasome signaling, summarize the
diversified roles of this receptor in host defense and inflammation, and cover recent updates
regarding its structure, inflammasome assembly, and regulation of microbiota.
1.2 NLRP6 assembles an inflammasome
The initial report of NLRP6 by Grainer et al. in 2002 using human cell lines
demonstrated that co-expression of NLRP6 (PYPAF5) and ASC leads to caspase-1 and NF-kB
activation in COS-7L and 293T cells, respectively [11]. Based on this observation, it was
assumed that NLRP6 could form an inflammasome like other members of the NLR family,
although in vivo evidence was lacking. The in vivo evidence of this was later provided by two
different laboratories at the same time in 2011 when they demonstrated that NLRP6-/- mice have
reduced serum IL-18 levels under steady state conditions [17] and after DSS-induced colitis [15,
17] compared to that of WT counterparts. However, IL-1β, which is regarded as one of the
signature cytokines of inflammasome activation, was found to be upregulated in the colon of
NLRP6-/- mice [15]. This may be due to redundant functions of other inflammasome complexes.
Nonetheless, Levy et al. demonstrated that NLRP6 co-localizes with ASC in intestinal cells
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under steady-state conditions to form an inflammasome thus, confirming that NLRP6 assembles
an inflammasome in vivo [18]. However, this finding did not hold true during microbial
infection. Anand et al. reported that they did not observe any obvious difference in the levels of
IL-1β or caspase-1 processing between NLRP6-/- and WT mice during different bacterial
infections including Salmonella, Listeria, and E. coli [14]. Therefore, at this time, it remained
unclear whether NLRP6 forms an inflammasome during systemic bacterial infections.
Recently, we [13] and others [19] reported that the NLRP6 inflammasome is activated
during bacterial infections. In our study, NLRP6-/- bone marrow-derived macrophages (BMDMs)
showed reduced caspase-1 processing and IL-β secretion compared to that of WT BMDMs when
infected with methicillin-resistant Staphylococcus aureus (MRSA). Consistently, MRSAinfected NLRP6-/- mice had reduced IL-1β secretion in bronchoalveolar lavage fluid (BALF)
compared to that of WT mice. This is strong evidence that NLRP6 assembles an inflammasome
during microbial infection. We observed that the NLRP3 inflammasome was intact in NLRP6-/BMDMs as treatment with NLRP3 agonist enhanced IL-1β production in these macrophages. As
reported by Greiner et al. and Levy et al. [11, 18], we found that NLRP6 colocalizes with ASC in
bone marrow-derived macrophages (BMDMs) after infection [13]. Similarly, an excellent study
from Hara et al. reported that Gram-positive bacteria, such as Listeria monocytogenes, activate
the NLRP6 inflammasome. More importantly, the authors demonstrated that lipoteichoic acid
(LTA) from L. monocytogenes upregulates the expression of NLRP6 and caspase 11 via type 1
IFN signaling, which could be regarded as the first signal. As a second signal, LTA serves as a
ligand to bind NLRP6 in order to activate the inflammasome via the ASC-caspase 11-caspase 1
signaling cascade [19] (Fig. 1.2). However, further investigations are warranted to determine
how S. aureus upregulate NLRP6 expression in macrophages. Being a gram-positive bacterium,
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it is possible that toxins from S. aureus could also activate type 1 IFN signaling, as in the case of
Listeria [19], or regulate TLR signaling, as in the case of NLRP3 [2], to upregulate expression of
NLRP6.

Figure 1.2. Activation of NLRP6 inflammasome during Listeria and S. aureus infection.
Activation of NLRP6 inflammasome during Listeria and S. aureus infection. Cytosolic delivery
of Listeria or its toxin (LTA) upregulates the expression of caspase-11 and NRLP6 via triggering
Type 1 IFN signaling in a macrophage. NLRP6 will recruit ASC (via PYD-PYD interaction),
and caspase 1 and caspase 11(via CARD-CARD interaction) to form NLRP6 inflammasome
complex. The activated inflammasome cleaves pro-IL-1β and pro-IL-18 into active form of IL1β and IL-18 which are then secreted from the cell for further immune response. During S.
aureus infection, NLRP6 is upregulated and recruits ASC and caspase-1 as mentioned above to
form NRLP6 inflammasome complex. Inactive form of IL-1β and IL-18 will be converted into
their respective active form for further immunological response. PYD: pyrin domain, LRR:
leucine-rich repeats; CARD: caspase activation and recruitment domain; LTA: lipoteichoic acid.
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1.3 Mechanism of NLRP6 inflammasome activation
In general, an inflammasome consists of a sensor component, an adapter molecule, and
an effector component (Fig. 1.1). The sensor molecule consists of either a PYD or CARD at its
N-terminus, the adapter molecule, usually ASC, consists of PYD and CARD domains, and the
effector component has a CARD at its end. Based on the sensor component, inflammasomes can
be broadly classified into three groups: NLR-associated inflammasomes, absent in melanoma-2
(AIM-2)-like receptor (ALR)-associated inflammasomes, and the Pyrin inflammasome [20, 21].
Based on the requirement of adapter molecules, inflammasomes can be either ASC-dependent or
ASC-independent (NAIP/NLRC4 inflammasome, where NAIP acts as a sensor and NLRC4 acts
as the adaptor molecule) [22]. Similarly, based on the effector component, inflammasomes can
be canonical (activate caspase 1) or non-canonical (activate caspase 11). All NLR-related
inflammasomes are canonical inflammasomes; however, all canonical inflammasomes are not
NLR-associated inflammasomes (for example, AIM2).
Inflammasome auto activation is thought to be prevented by the closed conformation of
the LRR and NACHT domains of NLR (autoinhibition) in the absence of ligand [23]. Upon
stimulation by ligands, the homotypic interaction between component proteins leads to the
assembly of an inflammasome. During assembly of the NLRP6 inflammasome, NLRP6 protein
recruits the bipartite ASC adapter molecule via a homotypic PYD-PYD interaction. ASC then
recruits caspase-1 via a CARD-CARD interaction to form the NLRP6-ASC-caspase-1
supramolecular complex known as the NLRP6 inflammasome, which facilitates the autocleavage of caspase-1 [24]. Biochemical studies have reported prion-like properties of PYD and
CARD filaments that facilitate inflammasome assembly. Recently, Cai et al. and Lu et al.
demonstrated that prion-like polymerization of ASC into filamentous structures is an important
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step in the activation of ASC-dependent inflammasomes [20, 25]. Based on the cryoelectron
microscopy structure and structure-based mutagenesis, ASC-dependent inflammasomes were
found to share a unified assembly mechanism that involves two nucleation-induced
polymerization steps [20, 26]. The first step being nucleation of ASCPYD filaments by NLRPYD
through a PYD-PYD interaction that leads to polymerization of ASC. In the second step, the
polymerized ASCCARD nucleates caspase-1CARD filaments via a CARD-CARD interaction for
caspase-1 activation. Activated caspase-1 is responsible for maturation of pro-IL-1β and proIL18 as well as gasdermin-D mediated pyroptosis [27]. Recently, the detailed filamentous and
crystal structure of the NLRP6 inflammasome was resolved by Shen et al. using biochemical and
biophysical methods. The authors purified full-length NLRP6 (NLRP6FL), NLRP6PYD, and
NLRP6PYD+NBD through affinity and size exclusion chromatography and tested their ability to
induce ASCPYD polymerization. All NLRP6 constructs were able to promote ASCPYD
polymerization. However, compared to NLRP6PYD, NLRP3PYD alone was not sufficient to
induce ASCPYD polymerization [24]. NLRP6PYD filaments possess a hollow cylindrical structure
that assembles through a right-handed helix, and a single NLRP6PYD contains six anti-parallel α
helices. During activation, most of the conformational changes in NLRP6 occur between the α2
and α3 loop to facilitate interactions [24].
Compared to AIM2PYD, the α2-α3 loop of NLRP6PYD is longer suggesting that NLRP6PYD
permits more degrees of conformational change during filament formation than does AIM2PYD
[24, 28]. Both NLRP6 and NLRP3 share similar molecular structures with slight differences in
the PYD component. However, while NLRP6PYD is capable of nucleating ASCPYD by itself,
NLRP3PYD is not able to provide a sufficient platform for ASC assembly [20, 24]. Like NLRC4,
upon overexpression the full-length NLRP6 assembles into an open and active filamentous
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conformation with the PYD filament in the center and LRR+NBD outside. However, the
LRR+NBD ring was more ordered in NLRC4 than in NLRP6 [24, 29]. Since, NLRP6 has been
shown to recruit both caspase 1 and caspase 11 during inflammasome assembly [19], future
biochemical studies are needed to provide additional mechanistic insight into NLRP6
inflammasome assembly.
1.4 NLRP6 in host defense
Inflammasomes have been shown to regulate host defense mechanisms under different
disease conditions [13, 30-32]. The role of the NLRP3 inflammasome in response to bacterial,
viral, and fungal infections has been well established [33-37], and there is mounting evidence
that NLRP6 also regulates host defense during different microbial infections (Table 1.1). An
interesting study by Anand et al. reported that NLRP6 negatively regulates innate immunity
during bacterial infections [14]. In this study, deletion of NLRP6 was found to enhance NF-κB
and MAPK activity resulting in increased neutrophil recruitment to the lungs. This augmented
neutrophil accumulation was associated with enhanced bacterial clearance and improved survival
in NLRP6-/- mice infected with Listeria, Salmonella, or E coli. However, the authors neither
depleted neutrophils nor blocked NF-κB or MAPK pathways to confirm this claim. Interestingly,
the authors did not find differences in the level of IL-1β or caspase-1 processing indicating that
the host protection conferred by NLRP6 deficiency was inflammasome independent. In addition,
NLRP6 regulated bacterial infection independently of microbiota composition as the co-housed
NLRP6-/- mice demonstrated a reduced bacterial burden compared to that of singly housed mice.
However, this study did not elucidate how NLRP6 recognizes these bacteria to initiate immune
signaling cascades.

8

Table 1.1 NLRP6 in host defense following microbial infection
Pathogens
S. aureus

L.
monocytogens

Model used Phenotype
observed
Pneumonia NLRP6-/- mice
(IT)
protected

Systemic
infection
(IV)

NLRP6-/- mice
protected

S. typhimurium Systemic
infection
(IV)
S. typhimurium Systemic
infection
(IP)

No change in
phenotype

E. coli

Systemic
infection
(IP)
Enteritis
model

NLRP6-/- mice
protected

Systemic
infection
(EMCV: IP
& oral;
Norovirus:
oral)

NLRP6-/- mice
susceptible

C. rodentium

Encephalomyo
carditis virus
(EMCV),
Norovirus

Proposed mechanism of action

Refs

NLRP6 augments pyroptosis and
necroptosis of neutrophils and
macrophages thereby reducing the
number of phagocytes to clear
bacteria. In addition, NLRP6
deficiency enhances IFN-γ
secretion in the lungs.
NLRP6 inflammasome enhances
IL-18 secretion, which is
detrimental during Listeria
infection.

[13]

[19]

[19]

NLRP6-/- mice
protected

NLRP6 deficiency augments NFκB mediated neutrophil
recruitment, which is important to
limit Salmonella.
NLRP6 negatively regulates the
NF-κB signaling pathway to
enhance neutrophil recruitment
NLRP6-/- mice have a thin mucus
layer as a result of defective goblet
cell function. This facilitates
prolonged adherence of C.
rodentium in the intestinal
epithelium.
NLRP6 recognizes cytosolic long
dsRNA and activated
mitochondrial antiviral signaling
proteins (MAVS) to enhance the
antiviral response. NLRP6-Dhx15MAVs axis augments the
expression of interferon-stimulated
genes to limit virus in the intestine.

NLRP6-/- mice
susceptible

[14]

[14]

[12]

[38]

We recently demonstrated that NLRP6 serves as a negative regulator of pulmonary host
defense during Gram-positive bacterial infection of the lungs [13]. MRSA has been shown to
induce necroptosis in the lungs resulting in pathology [39]; however, how the necroptosis
9

machinery is regulated in the lungs has remained unclear. We reported that activated NLRP6
triggers necroptosis and pyroptosis of macrophages and neutrophils in the lungs, which
ultimately reduces neutrophil numbers thereby compromising bacterial clearance (Fig. 1.3).
Through co-housing of NLRP6-/- mice with WT mice we further demonstrated that NLRP6
aggravates MRSA infection independent of microbiota composition. It is interesting that
pyroptosis, which was reported to be essential for protection against intracellular pathogens [40],
was found to be detrimental during pulmonary MRSA infection. These observations indicate that
role of pyroptosis may depend on the lifestyle of a pathogen. For intracellular pathogens,
pyroptotic cell death may kill the pathogen along with the cell itself. However, extracellular
pathogens might hijack NLRs, such as NLRP6, NLRC4 [30] or NLRP3 [34], to induce
pyroptotic cell death that exacerbates inflammation-induced pathology resulting in detriment to
the host. In addition to S. aureus-induced pneumonia, it would be revealing to study whether the
NLRP6 inflammasome exerts deleterious or protective effects during Gram-negative bacteriainduced pneumonia, since Gram-negative pathogens have their own lifestyles, virulence factors,
and immune evasion strategies.
Recently, an elegant study from Hara and colleagues demonstrated that LTA from
Listeria binds with NLRP6 and activates the NLRP6 inflammasome via ASC to regulate host
defense during Gram-positive bacterial infection [19]. It is interesting that NLRP6 activates both
caspase 11 and caspase 1 upon binding of LTA or Listeria for processing of IL-1β and IL-18. In
contrast, NLRP3, AIM2, and pyrin inflammasomes do not activate caspase 11. Upon infection
with Listeria, NLRP6-/- and caspase 11-/- mice had reduced bacterial burdens in several organs
and better survival compared to that of WT mice, thus confirming that NLRP6 is detrimental
during systemic Gram-positive pathogen infection. This protection was abolished when these
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mice received recombinant IL-18, but not IL-1β, suggesting that the NLRP6 inflammasome
exacerbates Listeria infection via IL-18 production (Fig. 1.3). In addition, the authors co-housed
NLRP6-/- mice with WT mice for 4 weeks to determine if the protection observed in NLRP6-/mice is microbiota dependent. Interestingly, NLRP6/caspase 11 signaling regulates Listeria
infection independently of microbiota. However, future studies are essential to understand how
IL-18 exacerbates Listeria infection as IL-18 has been shown to play protective as well as
deleterious roles during such infections. In the same study, the authors also infected WT and
NLRP6-/- mice with Salmonella and observed bacterial growth in the liver and spleen. In contrast
to what was observed by Anand et al, no differences were observed between WT and NLRP6-/mice [14]. It is difficult to explain this discrepancy in results as both studies used similar
bacteria, and doses, and almost similar routes of infection (IV vs IP). One explanation could be
due to difference in route used; however, further investigations are warranted to resolve this
controversial finding.
Although most studies of microbial infections have presented NLRP6 as a negative
regulator of host defense, some studies have reported essential roles for this molecule.
Wlodarska and colleagues utilized a murine model of Citrobacter-induced enteritis and found
that NLRP6 deficiency results in impaired host defense [12]. Intestines from NLRP6-/- mice were
extensively colonized with C. rodentium and the NLRP6-/- mice displayed extensive mucosal
ulceration, edema, and hyperplasia compared to WT mice. Interestingly, the authors found that
NLRP6 inflammasome signaling was essential for mucus secretion from goblet cells, which is
required as a physical barrier between microbiota and the underlying epithelium. Thus, the thin
mucus layer observed in NLRP6-/- mice appears to facilitate persistent adherence of C. rodentium
(Fig. 1.3). However, it is important to note that the authors did not investigate the functions of
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innate immune cells such as macrophages and neutrophils in the clearance of C. rodentium.
Therefore, whether NLRP6 regulates the recruitment or functions of these cells during such
infections remain unclear.

Figure 1.3 NLRP6 inflammasome in host defense during microbial infection. A) Pulmonary
infection with S. aureus activates NLRP6 inflammasome that triggers inflammatory modes of
cell death particularly necroptosis and pyroptosis in the lungs. NLRP6 increases the expression
of MLKL and RIP3 to induce necroptosis and caspase 1 and gasdermin-d to induce pyroptosis.
As a result of increased cell death, the number of phagocytic cells will be reduced in the lungs
that impairs Staphylococcal clearance. B) Systemic infection with Listeria monocytogens
activates NLRP6-ASC-caspase1/11 inflammasome complex in the macrophage. The activated
caspase 1 cleaves inactive IL-18 into active IL-18 which is then secreted from the cell. Thus
produced IL-18 enhances mortality during Listeria infection. C) NLRP6 recognizes cytosolic
dsRNA of encephalomyelitis virus via NLRP6-Dhx15 viral sensing complex in the enterocyte.
This complex will further activate Mavs to induce the transcription of Type I/III interferons and
IFN-stimulated genes for antiviral response. GSMD: Gasdermin d; MAVs: mitochondrial
antiviral signaling protein; Dhx15: DEAH-box helicase 15.
In addition to bacterial infections, a role for NLRP6 in viral infections has also been
reported. Wang and colleagues were the first to demonstrate that NLRP6 plays a crucial role in
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limiting viral infections [38]. While WT and NLRP6-/- mice exhibited no difference in survival
when infected intraperitoneally with encephalomyocarditis virus (EMCV), a +ssRNA virus, the
NLRP6-/- mice had higher viral loads in the intestine, but not in blood, brain, or heart. This
suggests that NLRP6 may have an important role in viral clearance from the intestine.
Interestingly, NLRP6-/- mice display increased susceptibility to EMCV when it is administered
orally, and similar results were obtained for oral infection with murine norovirus. In addition, the
authors performed co-housing experiments to determine if this phenotype is dependent on the
composition of the gut microbiome in mice and found that this was not the case. Interestingly,
NLRP6 interacts with the Dhx15 helicase to form a viral sensing complex that recognizes
cytosolic long dsRNA and activates mitochondrial antiviral signaling proteins (MAVS) to
initiate the antiviral response. Activation of the NLRP6-Dhx15-MAVs axis enhances the
expression of interferon-stimulated genes essential for limiting virus replication in the intestine
(Fig. 1.3). Further, expression of NLRP6 in the intestine following viral infection is regulated by
type I/III IFNs via the IRF3/7 transcription factors [38]. Given that NLRP6 has detrimental roles
in Gram-positive bacterial pneumonia [13], it would be of interest to investigate whether NLRP6
exhibits a protective or detrimental role in pulmonary host defense during infection with
influenza or rhinoviruses.
While it is clear that NLRP6 executes essential roles to protect the host against bacterial
and viral infections in the intestine, where it is highly expressed, in systemic and pulmonary
infections, NLRP6 expression appears to have detrimental effects. Thus, NLRP6-mediated host
defense regulation is likely context-dependent. In bacterial infections, where myeloid cells are
most important, NLRP6 seems to trigger destructive inflammation; however, during enteritis,
where non-hematopoietic cells (epithelial cells) play crucial roles, the NLRP6-mediated immune
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response is protective. Nonetheless, more studies will be necessary to further define the role of
NLRP6 in these systems. Moreover, whether NLRP6 exerts similar effects in viral, fungal, or
Gram-negative bacterial pneumonia and sepsis remains obscure. Defining the roles of NLRP6 in
these infections will allow for better generalization of these conclusions.
1.5 NLRP6 in intestinal microbiota
NLRP6 is highly expressed in the small and large intestine, especially in enterocytes,
colonic goblet cells, and myofibroblasts [15, 17, 41] and hence, most studies on NLRP6 have
concentrated on defining its role in these organs. A pioneer study by Elinav et al. involving 16S
rRNA analysis of fecal samples from non-littermate NLRP6-/-, ASC-/-, and IL-18-/- mice revealed
distinct microbiota composition in the guts of these mice compared to that of wild-type (WT)
mice. For example, there was a higher prevalence of anerobic taxa Prevotellaceae and TM7 [17].
These mice are also more susceptible to DSS-induced colitis than are WT mice. This alteration in
the microflorae is considered to be colitogenic since transfer of microbiota from NLRP6-/-, ASC/-

, or IL-18-/- mice to WT mice via cohousing for 4 weeks results in enhanced susceptibility of

WT mice to colitis. Intriguingly, depletion of microbiota using broad-spectrum antibiotics
reversed this phenomenon. Moreover, reduced IL-18 and increased CCL5 secretion in NLRP6-/mice led to altered microbiota and spontaneous intestinal inflammation [17] (Fig. 1.4). This
finding was crucial to document the prominent role of NLRP6 in maintaining intestinal
microbiota. In line with this finding, several studies using mouse models confirmed that the
NLRP6 inflammasome regulates gut microbiota [14, 18, 42]. Furthermore, Levy et al.
demonstrated that ex-germ-free NLRP6-/- mice develop dysbiosis as early as 3 weeks after
spontaneous recolonization compared to their ex-germ-free WT counterparts [18]. Since
microbiota can influence various physiological conditions [43] and diseases, this finding opened
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a new research platform for investigation of the possible roles of the NLRP6 inflammasome in
several physiological conditions such as colitis, tumorigenesis, and metabolic diseases including
non-alcoholic fatty liver disease and obesity [42, 44-46].

Figure 1.4 NLPR6 inflammasome orchestrating microbiota-epithelium interface. NLRP6
inflammasome maintains healthy microbiota in the gut via IL-18 secretion. Microbial metabolite
such as taurine activates NLRP6 inflammasome in the enterocyte to secrete IL-18. Genetic
ablation of NLRP6 will result into dysbiosis formation and increased secretion of CCL5 in the
intestine that lead to spontaneous inflammation and susceptibility to chemical-induced colitis.
Additionally, NLRP6 inflammasome maintains physical and chemical barrier between
microbiota and underlying epithelium to maintain healthy microbiota-epithelium interface.
Microbiota-derived LPS, Lipid A, and flagellin activates Myd88-ROS pathway to activate
NLRP6 inflammasome in the goblet cells. Activated NLRP6 inflammasome facilitates the
exocytosis of muc2 from goblet cells that forms physical barrier above the epithelium. On the
other hand, IL-18 derived from NLRP6 inflammasome in the enterocyte triggers the production
of antimicrobial peptides (AMP) that forms chemical barrier between microbiota and underlying
epithelium. ROS: reactive oxygen species, CCL5: CC-motif chemokine ligand-5; LPS:
lipopolysaccharides.

15

Non-genetic factors such as differences in animal housing [47], familial transmission [48]
, and diet [49] can modulate microbiota composition, suggesting that littermates are the best
control animals to use when investigating the impact of host genetic factors on microbiota
regulation. Recently, a study by Robertson and colleagues compared co-housing and F2generation littermate methods for standardization of microbiota between two different sources of
mice. Interestingly, the littermate method yielded uniform normalization of microbiota in feces,
colon, and ileum. However, extended co-housing was only able to normalize fecal microbiota
and the microbial community in the colon and ileum remained stable [50]. Using separately
housed, non-littermate WT and NLRP6-/- mice, Mamantopoulos et al. did not observe any overall
difference in microbiota composition, which is in contrast with the findings from Elinav et al.
[17, 51]. However, Porphyromonadaceae and Bacteroidaceae, but not the Prevotellaceae,
bacteria were differentially represented in these mice. Using distance-based redundancy analysis,
they found that these differences are due to mother and cage covariates rather than host genetic
factors (NLRP6). Furthermore, they did not observe obvious differences in microbiome
composition when using littermates (NLRP6+/+) even after lifetime separate housing [51]. In
support of this finding, Lemire et al. also demonstrated that NLRP6 does not impact gut
microbiota composition by using littermate NLRP6-/- and NLRP6+/+ mice [52]. Similarly, Galvex
et al. also reported similar microbial compositions of WT, NLRP6-/-, and Rag2-/- mice under
pathobiont-free conditions. Recently, results contradicting these were reported both by Levy et
al. and by Seregin et al. [45, 46]. These two studies also used littermate NLRP6-/- and NLRP6+/+
mice and analyzed their microbiota but found different microbial populations in NLRP6-/compared to NLRP6+/+ littermates. It is difficult to explain these contradictory results as both
studies used littermate NLRP6-/- and NLRP6+/+ mice and 16s RNA sequencing to analyze
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microbiota composition. Nonetheless, one possible explanation could be differences in
microbiota among different facilities due to unique husbandry practices, including chow
formulations and housing conditions, which could influence phylogenetic diversity and richness.
Another explanation could be the differences in algorithms or analysis software used. These
factors need to be considered when investigating microbiota-driven phenotypes in mouse
models. Moreover, use of littermate control animals should be utilized over co-housing to
normalize microbiota between different mice.
1.6 NLRP6 in epithelial integrity, and microbiota-epithelial crosstalk
The intestine contains trillions of commensal microbes that are beneficial to the host
under normal conditions [53]. Two sheets of mucosal layers and underlying epithelium prevent
direct contact of these commensal microbes with the lamina propria of the intestine. The outer
mucosal layer is blanketed by muc2 mucin secreted by goblet cells and serves as a habitat for
commensal microbiota [54-56]. Breaching of the mucin layer leads to aberrant crypt morphology
and can result in subsequent invasive adenocarcinoma and colorectal cancer [57]. Interestingly,
the NLRP6 inflammasome has been linked to epithelial integrity through regulation of goblet
cell function [12, 58] and secretion of antimicrobial peptides by enterocytes [18]. Wlodarska et
al. reported that NLRP6 inflammasome signaling is essential for optimal mucin secretion by
goblet cells. NLRP6-/- mice demonstrate reduced autophagy and hyperplasia of goblet cells with
a failure to exocytose mucin granules. As a result, these mice have only a thin mucus layer over
the epithelium and increased susceptibility to enteric infections [12] (Fig. 1.4). However, how
the NLRP6 inflammasome is activated in the intestine in response to microbiota was not clearly
defined in this study. To this end, Birchenough et al. demonstrated that metabolites from bacteria
activate the NLRP6 inflammasome for regulation of goblet cell function. Microbial metabolites
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such as LPS, lipid-A, P3CSK4 and flagellin, but not LTA or bacterial DNA, are endocytosed by
sentinel goblet cells via the TLR-MyD88 pathway and then induce intracellular reactive oxygen
species (ROS). These ROS further activate the NLRP6 inflammasome to regulate compound
exocytosis of goblet cells for muc2 secretion [58] (Fig. 1.4). Since ROS plays an upstream role
in NLRP3 inflammasome activation [59], it is possible that they serve as a common upstream
mediator of inflammasome activation. In the study by Birchenough and colleagues, the nature of
the cell death involving the extrusion of goblet cells was not delineated. Thus, it may be noninflammatory in nature, occurring through a mechanism such as autophagy, as documented by
Wlodarska et al. [12]. Together, these studies propose NLRP6 as a pivotal regulator of the goblet
cell-derived protective mucin layer, which serves as a physical barrier to protect underlying
epithelial integrity (Fig. 1.4).
NLRP6 has also been shown to regulate antimicrobial peptide secretion to form a
protective chemical barrier between microbiota and epithelium [18]. For example, microbiotaderived metabolites such as Taurin acetate induce IL-18-mediated AMP secretion via activation
of the NLRP6 inflammasome (Fig. 1.4). However, how these AMPs restore normal microbiota in
the dysbiotic environment remains elusive. Thus, further investigation is warranted to determine
whether AMPs selectively kill harmful bacteria or act as a probiotic to nourish useful bacteria in
the gut. Similarly, studies are needed to further confirm the role of IL-18 in intestinal
homeostasis and colitis as activation of IL-18 has also been shown to enhance loss of goblet cells
resulting in decreased epithelial integrity [60]. It is possible that NLRP6-dependent IL-18 plays a
protective role in maintaining epithelial integrity, while inflammasome-independent IL-18 has a
deleterious effect. Thus, future studies are essential to resolve the current controversy regarding
the function of IL-18 in the intestine.
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1.7 NLRP6 in metabolic diseases and carcinogenesis
Studies using mouse models have demonstrated that NLRP6 augments progression of
non-alcoholic fatty liver disease (NAFLD) and obesity through regulation of gut microbiota [42].
After feeding mice a methionine-choline-deficient diet (MCDD) for 4 weeks, Henao-Mejia and
colleagues found increased severity of NAFLD and non-alcoholic steatohepatitis (NASH) in
inflammasome-deficient mice (Asc-/- and Casp1-/-) compared to WT mice. Further, this was
mediated by IL-18 since IL-18-/-, but not IL-1b-/-, mice displayed a phenotype similar to Asc-/- and
caspase1-/- mice. Moreover, co-housing WT mice with Asc-/-, Casp1-/-, IL18-/-, or NLRP6-/- mice
enhanced the severity of NAFLD and NASH compared to singly housed WT mice indicating that
the augmented susceptibility is mediated by differences in microbiota composition regulated
through the NLRP6-IL-18 signaling axis. Translocation of metabolites from the altered
microflora in the gut of these mice via the portal vein activated TLR4 and TLR9 in the liver to
exacerbate NAFLD and NASH via TNF-α secretion [42] (Fig. 51.). This study provides strong
evidence that microbiota composition can dictate metabolic conditions, including diet induced
NAFLD and obesity. Consistent with this finding, a study by Lee and colleagues showed
increased levels of IL-1β upon LPS treatment of mice fed a high-fat diet suggesting involvement
of inflammasomes in NAFLD. Moreover, treatment of hepatic cell lines (Hep G2) with palmitic
acid and LPS upregulated the NLRP6 inflammasome, an effect which was reversed by
pretreatment with peroxisome-proliferator activated receptor-δ agonist (PPAR-δ), a nuclear
receptor protein [61]. However, this study did not reveal how PPAR-δ communicates with
NLRP6 to induce inflammasome activation.
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Figure 1.5 NLRP6 inflammasome regulating gut-liver axis. In a normal WT mouse, NLRP6
inflammasome maintains healthy epithelial cell-microbiota axis via mucin and AMP production
by goblet cells and enterocyte respectively. When these mice are co-housed with NLRP6-/- mice,
colitogenic bacteria will outnumber normal healthy microbiota. TLR2 and TLR9 agonists
secreted from dysbiotic microbiota will reach liver through portal circulation where they activate
TLR2 and TLR9 respectively to induce TNF-α secretion. TNF-α will further enhance the
progression of NAFLD to NASH. AMP: antimicrobial peptide; NAFLD: non-alcoholic fatty
liver disease; NASH: non-alcoholic steatohepatitis
Another elegant study using a murine water avoidance stress (WAS) model reported that
NLRP6 inflammasome signaling is inhibited in WAS-induced enteritis via corticotrophin
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releasing hormone (CRH) secretion from the brain as a result of stress [62]. Further, this
inhibition of NLRP6 signaling led to dysbiosis-induced enteritis in stressed mice, which was
transferrable to non-stressed mice upon co-housing. Interestingly, WAS-induced NLRP6
inflammasome inhibition and associated intestinal pathology was reversed upon treatment with
PPAR-γ agonists [62]. However, how CRH inhibits NLRP6 inflammasome activation in the
intestine remains unknown. It is possible that dysbiotic microflora observed in co-housed, nonstressed mice could affect the expression of the NLRP6 inflammasome. Future studies are
needed to shed light on these issues.
NLRP6 deficiency has been implicated in the aggravation of chemical-induced colitis and
subsequent tumorigenesis [15]. Chen and colleagues induced chemical colitis in WT and
NLRP6-/- mice using dextran sulfate sodium (DSS) and found that NLRP6-/- mice had increased
colitis-induced mortality compared to WT mice. Further, NLRP6-/- mice displayed increased
susceptibility to colitis-mediated tumorigenesis and NLRP6 in hematopoietic cells was found to
be important for the prevention of inflammation-induced tumorigenesis [15]. However, the
authors did not investigate the molecular mechanism underlying the increased susceptibility to
tumorigenesis in NLRP6-/- mice. Soon after this report was published, Normand et al. also
reported that NLRP6 performs essential functions in the regulation of tissue repair necessary for
protection against chemical-induced colorectal carcinogenesis [41]. This study showed that
NLRP6 deficiency leads to dysregulated colonocyte proliferation and migration, thereby
facilitating tumor formation. RT-PCR analysis revealed increased expression of genes involved
in cell proliferation such as casein kinase ε (csnk1ε) and SMARRC1 along with the protooncogene Myc11 in the DSS-treated colon of NLRP6-/- mice [41] (Fig. 1.6). One year later,
another well-designed study by Hu et al. reported that the enhanced susceptibility to
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tumorigenesis in NLRP6-/- mice is microbiota-dependent. The aberrant microflora in these mice
caused increased transcription of CCL5 which, in turn, augmented epithelial proliferation via
increased IL-6 secretion [44] (Figure 6). However, future studies will be necessary to understand
the components of the altered microbiota that contribute to tumorigenesis. In another study,
overexpression of NLRP6 in gastric cancer cells enhanced the expression of P14ARF, P53, and
P21 while reducing the expression of Mdm2 and Cyclin D1, indicating that NLRP6 negatively
regulates carcinogenesis via the P14ARF-Mdm2-P53 tumor suppressor axis [63] (Figure 6).
Together, these observations establish NLRP6 as a negative regulator of colorectal cancer and
suggest that modulation of NLRP6 may be a promising therapeutic alternative for its treatment.
1.8 NLRP6 in neuroinflammation
In addition to its role in host defense against bacterial and viral infection-induced
inflammation, NLRP6 has been shown to modulate neuroinflammation [16, 64]. In a murine
model of acute peripheral nerve injury, Ydens and colleagues reported that deletion of NLRP6
strongly impairs nerve function [16]. Further, the expression of both NLRP6 and NLRP3 was
found to be increased 4 hours after surgery-induced acute neurodegeneration. Intriguingly,
NLRP6-/-, but not NLRP3-/-, mice had a dramatic drop in the sciatic functional index (SFI) and
needed a longer recovery time, compared with WT mice, after crushing of the right sciatic nerve.
Furthermore, it was demonstrated that NLRP6 enhanced this recovery independent of
inflammasome activation. Thus, the authors proposed that enhanced MAPK activity observed in
NLRP6-/- mice could exacerbate inflammation resulting in delayed recovery from nerve injury.
Future studies will be necessary to shed more light on how NLRP6 enhances recovery from
peripheral nerve injury and how this could be manipulated for therapeutic intervention.
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Figure 1.6: NLRP6 regulating different mechanisms to prevent carcinogenesis. A and B) NLRP6
deficiency increased the expression of genes involved in cell proliferation such as casein kinase ε
(csnk1ε), ccl20, and SMARRC1 along with proto-oncogene Myc11 in the DSS-treated colon. C) NLRP6
prevents dysbiosis-induced IL-6 secretion thereby preventing abnormal cell proliferation in the intestine.
D and E) NLRP6 augments the expression of P14ARF, P21, and P53 and suppresses Mdm2 and Cyclin-D
in gastric cancer cells to prevent tumor progression. Ccl20: CC-chemokine ligand 20; SMARRC1: a
member of switch/sucrose nonfermentable chromatin remodeling complex; Ccl5: CC-chemokine ligand
5; Mdm2: murine double minute 2.

In addition to the peripheral nervous system, a role for NLRP6 in the central nervous
system (CNS) has also been reported. In a murine model of intracerebral hemorrhage (ICH)induced brain injury, Wang et al. analyzed the expression profiles and biological functions of
NLRP6 [64]. NLRP6 expression was increased mainly in glial fibrillary acidic protein (GFAP)-
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positive astrocytes in the perihematomal brain after ICH downstream of TLR4 activation.
Interestingly, NLRP6-/- mice displayed severe brain injury as evidenced by increased edema, NFκB-mediated pro-inflammatory cytokine production, and aggravated neurological-deficit scores
compared to their WT counterparts. Since microbiota has been shown to regulate
neurodevelopmental disorders and promote the autism phenotype [65], it will be interesting to
explore whether microbiota in the gut has any influence on ICH-induced brain injury or in acute
peripheral nerve injury.
1.9 NLRP6 in human diseases
Most of the studies intended to define the expression and function of NLRP6 have been
performed in mouse models and very little research to date has involved human patients.
Consistent with the mouse model, genome-wide analysis based on gastrointestinal
transcriptomics revealed high expression of NLRP6 in the small intestine of healthy humans
[66]. Thus, as in mice, NLRP6 appears to have a specific role in the intestines of humans.
Recently, we reported higher expression of NLRP6 in neutrophils, macrophages, and epithelial
cells in the lungs obtained from pneumonia patients [13]. Consistent with this, MRSA-infected
mice also displayed enhanced expression of NLRP6 in these cells. While expression of NLRP6
has been shown to prevent colorectal cancer in murine models, gene expression analysis
performed in colorectal cancer patients showed no change in the expression of NLRP6 [67]. In
contrast, a genome-wide study linked a single nucleotide polymorphism in NLRP6 with platelet
volume [68] suggesting that NLRP6 could have an important role in thrombopoiesis or platelet
function. Interestingly, the expression of NLRP6 and IL-1β is increased in adipose tissue
obtained from portal fibrosis patients compared to that from control patients [69]. This is
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consistent with the important role of NLRP6 in NAFLD and obesity previously identified in
mice [42].
In another study of patients undergoing endodontic microsurgery, analysis of tissues
associated with apical periodontitis revealed higher expression of NLRP6 [70]. In addition, when
NRP6 was silenced in periodontal ligament cells and then stimulated with E coli-derived LPS,
both NF-κB and ERK signaling were found to be augmented as were secretion of IL-6 and TNFα. This suggests that NLRP6 suppresses the inflammatory response during periodontitis, which is
in line with mouse studies where NLRP6 has been reported to negatively regulate NF-κB and
ERK pathways [14]. A similar anti-inflammatory role of NLRP6 has been reported in
rheumatoid arthritis patients. In this study it was demonstrated that NLRP6 is downregulated in
synovial tissues and fibroblast-like synoviocytes (FLS) at both the transcription and translational
levels compared to that of osteoarthritis patients [71]. Silencing of NRP6 in FLS from
rheumatoid arthritis patients enhanced proinflammatory cytokine production via increased
activity of NF-κB in response to TNF-α. Furthermore, the authors reported that NLRP6 acts as a
docking site to facilitate the interaction between transforming growth factor-b-activated kinase-1
binding protein 2/3 and tripartite motif 38 (TRIM38) to promote lysosome-dependent
degradation [71]. It is interesting that NLRP6 was found to regulate lysosome-mediated
degradation, although future studies are needed to investigate if these findings have clinical
relevance in other diseases.
1.10 Concluding remarks
NLRP6 has multifaceted functions ranging from regulation of host defense during
microbial infections, composition of the epithelium-microbiota interface, and modulation of
inflammatory modes of cell death such as pyroptosis and necroptosis, to regulation of metabolic
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diseases, neuroinflammation, and cancer. Thus, the multitasking ability of NLRP6 makes this
inflammasome unique among NLR-family members. Although NLRP6 was first reported to
form an inflammasome in vitro in 2002, the long-standing conundrum regarding whether it can
assemble an inflammasome in vivo or during microbial infection was only recently resolved. It is
now known that NLRP6 recognizes Listeria (LTA) and S. aureus and forms an inflammasome
complex along with ASC to regulate host defense. Of interest is the finding that NLRP6 recruits
both caspase 1 and caspase 11 to form an inflammasome, whereas other NLR family members
recruit only one or the other. Thus, future biophysical and biochemical studies are essential to
understand how caspase 11 is recruited along with caspase 1 during NLRP6 inflammasome
assembly. Additionally, there likely remain many unknowns regarding this pathway as new
inflammasomes, sensors, and downstream signaling pathways are constantly being elucidated.
Currently there are large discrepancies regarding the role of NLRP6 in the composition of
gut microbiota. Future studies are essential to address this controversy. Moreover, a unanimous,
comprehensive protocol should be established through a consortium in order to bring uniformity
in microbiota research.
While most of the research studies regarding NLRP6 have concentrated on the gut, the
role of this molecule in host defense has also gained considerable attention. For example, a
detrimental role of NLRP6 in innate immunity of the lungs has recently been described [13].
However, the function of this inflammasome in host defense during pathogen infections in other
organs, including heart, brain, kidneys and neurons, remains unexplored. In addition, it will be of
interest to investigate how NLRP6 regulates immunity during fungal infections and sepsis.
Future studies in these areas will enhance our current understanding of the role of NLRP6 in host
defense mechanism.
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Several studies have suggested that the function of NLRP6 is context dependent. While
this molecule is important for limiting infections in the intestines, it appears to be detrimental to
host defense in the lungs. This may be explained by the cell types present in these tissues. During
infections, expression of NLRP6 in myeloid cells such as macrophages and neutrophils appears
to be detrimental; however, epithelial cells expressing NLRP6 might play protective roles.
Further investigation will be required to understand the cell and organ-specific functions of
NLRP6. Studies involving deletion of NLRP6 in specific cell compartments, such as myeloid
cells, epithelial cells or lymphocytes, could generate more conclusive findings. The future
challenge will be to apply our current knowledge of inflammasome biology to attenuate the
tissue injury induced by uncontrolled inflammation through the use of specific treatment
strategies in the context of the acute and chronic stages of both infectious and non-infectious
diseases.
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CHAPTER 2. NLRP6 NEGATIVELY REGULATES PULMONARY HOST DEFENSE
DURING GRAM-POSITIVE BACTERIAL INFECTION THROUGH MODULATING
NEUTROPHIL RECRUITMENT AND FUNCTION
2.1 Introduction
Acute pneumonia is a leading cause of childhood mortality (<5 years of age) accounting
for the death of 920,136 children annually [1], and methicillin-resistant Staphylococcus aureus
(MRSA) has been implicated in severe life-threatening infections, including necrotizing
pneumonia and sepsis [2]. Further, S. aureus infection is also one of the major causes of
secondary pneumonia following influenza infection [3]. In addition, S. aureus has developed
resistance to multiple antibiotics and effective treatment strategies against this bacterium are
limited [2, 4]. Therefore, S. aureus is a serious threat to human health and novel therapeutic
strategies are needed.1
The lung pathology induced by S. aureus is attributed to virulence factors, the intense
inflammatory response, and evasion of host defense mechanisms, including neutrophil-mediated
ROS-dependent bacterial killing [5, 6]. Regarding innate immune responses, nucleotide-binding
oligomerization domain-like receptor (NLR) pyrin domain-6 (NLRP6) is a recently identified
NLR present in the cytosol of innate immune cells [7]. Co-transfection of plasmids containing
NLRP6 and apoptosis-associated speck-like protein containing card (ASC) in 293T cells led to
activation of NF-kB and in COS-7L cells to a synergistic increase in caspase-1 activation and IL1β secretion [8]. Under homeostatic conditions Levy et al have demonstrated that NLRP6 colocalizes with ASC and caspase-1 to form a complex resulting in IL-18 secretion from intestinal

This chapter has been published as Ghimire L, Paudel S, Jin L, Baral P, Cai S, Jeyaseelan S.
NLRP6 negatively regulates pulmonary host defense in Gram-positive bacterial infection
through modulating neutrophil recruitment and function. PLoS Pathog. 2018;14(9):e1007308.
Epub 2018/09/25. doi: 10.1371/journal.ppat.1007308. PubMed PMID: 30248149; PubMed
Central PMCID: PMCPMC6171945.
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epithelial cells, which is essential to prevent development of dysbiosis [9]. Together these results
suggest that NLRP6 can co-localize with ASC for inflammasome formation and activation.
However, the mechanisms of NLRP6 inflammasome activation and its role in host defense
specifically during pulmonary microbial infection has not been explored. Furthermore, it remains
unknown whether the NLRP6 inflammasome is activated by microbial infections and whether
NLRP6 co-localizes with ASC and caspase-1 during such infections to induce pyroptosis.
In a mouse model of systemic infection, Anand et al [7] found that the NLRP6
negatively regulates host defense against Listeria and Salmonella infections as NLRP6 KO mice
showed higher survival, decreased bacterial burden, and attenuated pathology compared to WT
mice. In contrast, a study reported by Wlodarska et al [10] revealed a positive regulatory role of
the NLRP6 inflammasome on immune function during enteric infection with Citrobacter
rodentium. In this investigation, NLRP6 KO mice were shown to have an increased C. rodentium
burden in the intestine, which correlated with extensive mucosal damage in the KO mice
compared with WT controls. However, these results cannot be extrapolated to other bacterial
infections in different organs, such as the lung, because Gram-positive bacteria have unique
virulence factors and immune evasion strategies and the route of administration of bacteria also
dictates host responses. Thus, the role of the NLRP6 inflammasome in pulmonary immunity
against Gram-positive infections remains unclear. To this end, we have used NLRP6 KO mice to
demonstrate how S. aureus exploits the NLRP6 inflammasome to dampen neutrophil function
and enhance pyroptosis and necroptosis to increase mortality during acute bacterial pneumonia.
Our results show NLRP6 as a potential therapeutic target for treatment of S. aureus-infected
pneumonic patients.

37

2.2 Methods
2.2.1 Ethics Statement. Mouse experiments were conducted in accordance with the
recommendations in the Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health. Animal protocols were approved by the Institutional Animal Care and Use
Committee (IACUC) at Louisiana State University (protocol number 16-072). All animal
experiments were performed in a manner to ensure minimal pain and distress.
2.2.2 Immunofluorescence microscopy. Immunofluorescence microscopy of lung sections was
performed as described previously [11]. Human lung sections from lungs without evidence of
infection or injury (control) or from patients who died due to bacterial infection with ALI/ARDs
(pneumonic) were used. Mouse lung sections were from saline-challenged or S. aureus-infected
mice. Lung sections were incubated with anti-NLRP6 (Abgent, CA) and antibodies for surface
markers including anti-lipocalin Ab for neutrophils (R&D Systems, MN), or anti-CD68 Ab for
macrophages (BioLegend, CA), and anti-CD326 Ab for alveolar epithelial cells (BioLegend,
CA). For mouse lung sections, we used antibodies for surface markers including anti-Ly6G for
PMNs (BioLegend, CA), anti-F4/80 for macrophages (BioLegend, CA), and anti-CD326 for
alveolar epithelial cells along with anti-NLRP6 Ab (Sigma, MO). Appropriate Alexa-conjugated
secondary antibodies (Invitrogen, CA) were used. For detection of necroptosis and pyroptosis
through an immunofluorescence assay, antibodies against mouse NLRP6 and ASC (Sigma, MO),
p-MLKL, (Abcam, MA), RIP3 (Cell signaling, MA), caspase-1 (Adipogen, CA), and gasderminD (Santa cruz, CA) were used. Excess antibodies were washed off, and the cells were labeled
with secondary antibodies, such as mouse IgG/IgM (H+L) Alexa fluor 488, 568 (Invitrogen,
CA). Images were obtained using an Axiocam digital camera (Zeiss, NY) connected to a Zeiss
Axioskop 2 Plus microscope.
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2.2.3 Immunoblotting and cytokine measurement. BMDMs or lungs were harvested at
designated time points and homogenized in PBS containing 0.1% Triton X-100 (phosphatase and
protease inhibitor cocktail added). After centrifugation the supernatants were used for
immunoblotting. Total protein content in the supernatant was measured using a BCA protein
assay kit (Thermofisher, NY) to ensure that equal amounts of proteins were loaded onto 10%
SDS-PAGE gels. Proteins were transferred to polyvinylidene fluoride membrane according to
the protocol provided by Bio-Rad. Appropriate primary antibodies against mouse NLRP6
(Sigma, MO), phospho-MLKL (Abcam, MA), RIP3, RIP1, P47phox, P67phox, gp91phox, phosphop38 MAPK, phospho-JNK, phospho-Stat3, ICAM-1, VCAM-1, caspase-8, GAPDH (Cell
Signaling, MA), caspase-1 (Adipogen), and gasdermin-D (Santa Cruz, CA) were added to the
membrane and incubated overnight at 40 C. Appropriate secondary antibodies were used, and the
films were developed using ECL plus western blot detection system (ThermoFisher, NY). IL-1β,
TNF-α, IFN-γ, IL-1α, and IL-6 were measured in BALF supernatants by ELISA according to the
manufacturer’s protocol (eBioscience, CA).
2.2.4 Animals. Eight to twelve-week-old WT mice (C57BL/6 background) were used. Equal
age- and gender-matched NLRP6 KO, ASC KO, and Caspase-1/11 DKO mice on the C57BL/6
background were used throughout the experiments. Mice were kept on a 12:12 hour light/dark
cycle under specific pathogen-free condition with free access to food and water. All animal
experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at
Louisiana State University.
2.2.5 Pneumonia model. To induce pneumonia, mice were anesthetized using ketamine (100
mg/kg) and xylazine (5 mg/kg) prior to intratracheal inoculation of S. aureus (USA 300 strain).
A small midline incision was made on the ventral aspect of the neck and excess fat was separated
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to expose the trachea. Fifty microliters of bacterial suspension containing 5X107 CFU of log
phase S. aureus in isotonic saline was injected into the lungs by piercing trachea using a 28.5gauge needle. At 12- and 24-hours post-infection, mice were euthanized to collect BALF, lungs,
and liver for quantification of bacterial burden and leukocyte recruitment. BALF and
homogenized organs were serially diluted and plated onto Tryptic soy agar (TSA) plates for
bacterial enumeration. For survival experiments, we used 2 X 108 CFUs/mouse of S. aureus and
observed survival for 12 days post-infection.
2.2.6 BALF collection. BALF was collected as described in our previous publication [11].
Briefly, after specific time points, mice were humanly euthanized, and the trachea was exposed.
Using a 20-gauge catheter, 0.8 ml of PBS (heparin and dextrose added) was instilled inside the
lungs and collected in a clean tube. The process was repeated a total of four times so that a
minimum of 2.8-3 ml of BALF was collected from each mouse. Total leukocyte count was
performed in a hemocytometer using 10 µl of BALF and the differential count was done under
light microscopy using cytospin slides stained with DiffQuik reagent. The remaining cell-free
BALF was preserved at -80o C for cytokine analysis.
2.2.7 Co-housing experiments. Co-housing experiments were performed as described by Anand
et al [7]. In brief, age and sex matched WT and NLRP6 KO mice were co-housed together in 1:1
ratio for 4 weeks. After co-housing, WT and the KO mice were infected with S. aureus (i.t.) and
euthanized 24 hours post-infection to measure the bacterial burden.
2.2.8 Bone marrow chimeras. Bone marrow chimeras were generated as described previously
[11, 12]. In brief, the recipient mice were lethally irradiated with a 1000-rad inoculum from a
cesium source. Bone marrow cells collected from healthy donor mice were injected into recipient
mice via tail vein (8 million cells per mouse). The chimeric mice were kept under 0.2%
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neomycin sulfate treatment for 15 days after transplantation. After 8 weeks of transplantation,
the chimeric mice were infected with 5X 107 CFU of S. aureus. The mice were euthanized at 24hour post-infection to estimate cellular recruitment and bacterial burden in the lungs.
2.2.9 Neutrophil depletion. For neutrophil depletion, mice were treated with 500 µg of antiLy6G antibody (clone 1A8, BioLegend, CA) [13] intra-peritoneally 24 and 2 hours prior to
infection with lethal inoculum of S. aureus (2 X 108 CFUs/mouse). For IFN-γ inhibition, mice
were treated with 100µg of IFN-γ antibody (BioXCell, NH) 12 hours prior to infection with S.
aureus. For caspase-1 inhibition, mice were treated with 100 µg of caspase-1 inhibitor (AcYVAD-CMK, Cayman chemical, MI) 12 hours prior to infection with S. aureus. For MLKL
inhibition, 100 µl of 100 µM MLKL inhibitor (GW806742X, Adipogen, CA) [14] was injected
into each mouse i.p. 12 hours prior to infection with S. aureus. For RIP1 inhibition, mice were
treated with 300 µg of necroptosis inhibitor (Nec-1/necrostatin-1s, Calbiochem, MA) [15] 18
hours before and at the time of bacterial infection, as published elsewhere [15]. Mice were
euthanized to collect BALF and organs 24 hours post infection.
2.2.10 Neutrophil killing assay. The intracellular killing assay was performed as described [16]
with slight modification. Briefly, bone marrow neutrophils from NLRP6 KO and WT mice were
isolated, infected with S. aureus (MOI: 10), and treated with gentamicin for 30 minutes at
designated time points post-infection (30 min, 60 min, 90 min, and 120 min) to kill extracellular
bacteria. Cells were washed several times with sterile PBS to remove excess gentamicin and
were then lysed with 0.1% triton X to release intracellular bacteria. The lysate was serially
diluted with PBS, plated onto the TSA, and incubated at 370 C overnight for bacterial load
estimation.
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2.2.11 ROS detection. Total neutrophils, isolated from bone marrow of WT and NLRP6 KO
mice using a magnetic negative selection cell isolation kit (STEMCELL Technologies,
Vancouver, Canada), were infected with S. aureus (MOI 10). Total intracellular ROS production
was quantified using a Fluorometric kit (AA Bioquest, CA). The effect of IFN-γ on ROS
production was determined by pretreating neutrophils with either 20 ng/ml of recombinant
mouse IFN-γ (R&D Systems, MN) or an equal volume of PBS for 30 minutes before infection
with S. aureus. The total ROS production was quantified after 30 minutes of infection using a
spectrophotometer.
2.2.12 Measurement of cell death. BMDNs were isolated from WT and NLRP6 KO mice and
pretreated with Nec-1s (300 µM) or Ac-YVAD-CMK (100 µg/ml) or DMSO for 30 minutes
before infection with S. aureus (MOI: 20). The percentage of cytotoxicity in BMDNs and LDH
release into the alveolar space after S. aureus infection were measured using the Cytotox-ONETM
homogenous membrane integrity assay kit (Promega, WI). HMGB-1 was measured using a
commercially available kit from Chondrex Inc, WA.
2.2.13 Statistics. Data are represented as mean ± SEM. The Mann-Whitney test was used to
compare the bacterial burden between two groups. Student’s t-test was used whenever the data
were parametric in nature. We used one-way ANOVA followed by Bonferroni’s multiple
comparison test wherever more than two groups were involved. All statistical analyses were
performed using GraphPad Prism 7 software. The survival curve was analyzed using Log-rank
(Mantel Cox) test. All experiments were performed thrice. Significant differences are indicated
by * (p<0.05), ** (p<0.01), *** (p<0.001), and **** (p<0.0001).
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2.3 Results
2.3.1 NLRP6 expression is increased in the lungs of pneumonic patients and S. aureusinfected mice
To determine whether NLRP6 is upregulated in the lungs of pneumonic patients, we
stained bacterial pneumonic and normal lung tissue sections with anti-NLRP6 antibody and
found that NLPR6 was upregulated in key innate immune cells in the lungs, such as neutrophils
(lipocalin-2+), macrophages (CD68+), and epithelial cells (CD326+) (Fig. 2.1A). Next, we
determined if NLRP6 expression is upregulated in S. aureus-induced pneumonia in mice. In line
with the results seen in human pneumonic lung sections, NLRP6 was upregulated in neutrophils
(Ly6G+), macrophages (F4/80+), and epithelial cells (CD 326+) of mouse lungs following S.
aureus infection (Fig. 2.1B). Consistent with the immunofluorescence results, the expression of
NLRP6 was also increased in lung lysates of human pneumonic patients, S. aureus-infected
human cell lines (THP-1 and HL-60), and mouse bone marrow-derived macrophages (BMDMs)
(Figs. 2.1C-E).
To investigate whether NLRP6 triggers inflammasome activation during S. aureus
infection, we infected BMDMs from WT and NLRP6 KO (KO) mice with S. aureus (MOI: 10)
and measured the extent of caspase-1 activation at 8 hours post-infection. Both cleaved caspase-1
(p-20) in macrophage lysates and IL-1β levels in culture supernatants following infection were
attenuated in the NLRP6 KO samples compared to the WT control (Figs. 2.1F and G) indicating
the activation of the NLRP6 inflammasome by S. aureus. S. aureus has several virulence
components, such as α-hemolysin (hla), clumping factor B, β toxin, phenol-soluble modulins,
and panton-valentine leukocidins [5] that could potentially activate the NLRP6 inflammasome.
Because hla has been reported to activate the NLRP3 inflammasome in human and mouse
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monocytic cells under similar conditions [17, 18], we investigated whether hla can also activate
the NLRP6 inflammasome in BMDMs and found this to be the case (Figs. 2.1E and F).

Figure 2.1. Upregulation and activation of NLRP6. (A) Lungs tissue sections from healthy and
pneumonic patients were stained with antibodies against neutrophils (lipocalin-2+), macrophages
(CD68+), and epithelial (CD326+) cells. NLRP6-positive cells are indicated by white arrowheads.
(B) Immunofluorescence microscopy was performed on lung sections from healthy and S.
aureus-infected mice to assess expression of NLRP6 as in A. NLRP6-positive cells are indicated
by white arrowheads. (C) NLRP6 expression was analyzed in lysates of human healthy control
tissue, pneumonic lung tissue, and HL-60 (human neutrophil-like) cells infected with S. aureus
(MOI10) for 4 hours. (D) THP-1 (human monocytic) cells were infected with S. aureus (MOI
20) or purified α-hemolysin (hla) for 8 hours and expression of NLRP6 was assessed by western
blotting. (E, F) Bone marrow-derived macrophages (BMDMs) were infected with S. aureus
(MOI: 20) or hla from S. aureus (50 µg/ml) for 8 hours (E). Expression of NLRP6 protein was
analyzed by immunoblotting. (F) Caspase-1 processing by the NLRP6 inflammasome in
response to S. aureus or hla in BMDMs. (G) IL-1β secretion by WT and NLRP6 KO BMDMs
following S. aureus infection. (H) IL-1β secretion by WT and NLRP6 KO mice after S. aureus (5
X 107 CFU/mouse) infection (N=6-8/group). (I) BMDMs from WT and NLRP6 KO mice were
infected with S. aureus (MOI: 50) and stained for NLRP6 (red) and ASC (green). The white
arrowheads demonstrate co-localization of NRP6 and ASC. (J) BMDMs from WT and NLRP6
KO mice were infected with S. aureus (MOI: 50) and stained for NLRP6 (red) and caspase-1
(green). The white arrowheads show co-localization of NRP6 and caspase 1. The graphs show
the mean ± SEM of three independent experiments. The images shown are the representative of
five different fields from three independent experiments. Magnification: 40X. SA: S. aureus,
hla: α-hemolysin. *, p<0.05, **, p<0.01, and *** p<0.001.
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Consistent with the in vitro results, NLRP6 KO mice showed lower levels of IL- 1β in
bronchoalveolar lavage fluid (BALF) after infection with S. aureus, providing evidence of
NLRP6 inflammasome activation in vivo (Fig. 2.1H). ASC is known to be an integral part of
NLRP3 inflammasome signaling although it is dispensable for NLRC4 inflammasome activation
[19]. We infected BMDMs with S. aureus and performed immunofluorescence assay to observe
whether NLRP6 co-localizes with ASC and caspase 1. We found that NLRP6 co-localized with
ASC and caspase-1 during S. aureus infection (Figs. 2.1I and J).
2.3.2 NLRP6 deficiency confers host protection during S. aureus-induced pneumonia
To assess the role of the NLRP6 inflammasome in pulmonary host defense against S.
aureus, we infected WT and NLRP6 KO mice intratracheally with a lethal dose of S. aureus
(USA 300) (2X108 CFUs per mouse) and observed the survival patterns for 10 days. Although all
WT mice died within 3 days, 70% of KO mice survived longer than 10-days post-infection (Fig
2A). Furthermore, ASC KO mice displayed a survival pattern similar to that of the NLRP6 KO
mice (Fig 2.2A). To determine whether the difference in survival is due to differences in the
bacterial burden of various organs, we measured the bacterial burden in the lung, BALF, and
extra-pulmonary organs after infecting mice with a sub-lethal inoculum (5X107CFU) of S.
aureus. As compared to NLRP6 KO mice, WT mice had higher bacterial burdens in the lungs,
BALF, and liver at both 12 and 24-hours post-infection (Fig 2.2B-D). Accordingly, the total
protein in the BALF, which is a measure of pulmonary leakage, was higher in WT mice
compared to their NLPR6 KO counterparts (Fig 2.2E).
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Figure 2.2. NLRP6-/- mice are resistant to pulmonary S. aureus infection. (A) WT, NLRP6 KO,
and ASC KO mice (N = 13-15/group) were infected intratracheally with a lethal inoculum of S.
aureus (USA 300) (2X108 CFU/mouse) and survival was then observed for 10 days. WT and
NLRP6 KO mice (N = 5-8/group) were infected intratracheally with a sublethal inoculum of S.
aureus (5 X 107 CFU/mouse) and then were euthanized 12 or 24 h post-infection to quantitate
the bacterial burden in (B) lungs, (C) BALF, and (D) liver. Total protein in BALF was measured
(E). WT and KO mice (N=6-8/group) were infected intratracheally with 5X107 CFU/mouse of S.
aureus (MSSA strain). Twenty-four-hours post-infection, the bacterial burden was measured in
lungs (F) and BALF (G). WT and KO mice (N=5/group) were co-housed for 4 weeks and
infected with a sublethal dose of S. aureus. Mice were euthanized at 24 hours post-infection to
estimate bacterial burden in the lungs (H) and BALF (I). Bone marrow chimeras were generated
as described in the methods (N=6-8/group) and then were infected with a sublethal dose of S.
aureus. At 24-hours post-infection, mice were euthanized to estimate bacterial burden in the
lungs (J) and BALF (K). *, p<0.05, **, p<0.01, and *** p<0.001.3.3

To determine whether the detrimental effects of NLRP6 are bacterial strain specific, we
infected WT and KO mice with a methicillin-susceptible Staphylococcus aureus strain (MSSA,
Newman strain) and measured the bacterial burden in lungs and BALF at 24-hours postinfection. Consistent with the results seen with the USA 300 strain, the bacterial burden of the
methicillin-sensitive strain was also higher in the lungs and BALF of WT mice compared to that
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of KO mice (Fig 2.2F and G). NLRP6 inflammasome has been implicated in regulating intestinal
microbiota [9, 20]. To determine if observed difference in the phenotype between WT and
NLRP6 KO mice is due to difference in gut microbiota, we co-housed WT and NLRP6 KO mice
for 4 weeks and infected them with S. aureus. As observed with non-co-housed mice, co-housed
NLRP6 KO mice had significantly less bacterial burden in the lungs and BALF as compared to
co-housed WT mice (Fig 2.2H and I). These data suggest that NLRP6 regulates pulmonary S.
aureus infection independent of microbiota composition.
2.3.3 Both hematopoietic and non-hematopoietic cells contribute to host susceptibility.
Since we found upregulation of NLRP6 in both hematopoietic (neutrophils and
macrophages) and non-hematopoietic cells (epithelial cells) (Fig 1.1B), we sought to determine if
NLRP6 from each of these compartments is detrimental to bacterial clearance of S. aureusinduced pneumonia. Using bone marrow chimeric mice, we found that WT mice that received
KO bone marrow (KO→WT) had lower bacterial burdens in the lungs and BALF than WT mice
that received WT bone marrow (WT→WT) (Fig 2.2J and K). However, KO mice that received
WT bone marrow (WT→KO) showed no increase in bacterial burden in the lungs and BALF
compared to KO mice that received KO bone marrow (KO→KO) (Fig 2.2J and K). Together,
these results suggest that NLRP6 derived from both hematopoietic and non-hematopoietic
compartments is detrimental for bacterial clearance during S. aureus pneumonia.
2.3.4 Enhanced host protection in NLRP6 KO mice is dependent on neutrophils.
Neutrophils have been shown to be essential for containing pulmonary Staphylococcal
infections [21, 22]. To determine if neutrophils confer augmented host protection in NLRP6 KO
mice, we depleted neutrophils in the KO mice prior to infection with a lethal dose of S. aureus
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and observed survival. We found that depletion of neutrophils reversed the survival benefit
observed in the NLRP6 KO mice suggesting that protection is neutrophil-dependent (Fig 2.3A).

Figure 2.3. Neutrophils confer host protection in NLRP6 KO mice. (A) NLRP6 KO mice (N=1012/group) were treated either with anti-Ly6G antibody or IgG2a, 24 and 2 hours prior to
infection with a lethal dose of S. aureus (USA300). Survival was monitored for 10 days. NLRP6
KO mice (N = 5-8/group) were infected intratracheally with a sublethal inoculum of S. aureus (5
X 107 CFU/mouse). Mice were euthanized 12- or 24-hours post-infection to estimate total
leukocytes (B), neutrophils (C), and macrophages (D) in the BALF. (E) Myeloperoxidase assay
was performed in the lungs. *, p<0.05, **, p<0.01, and *** p<0.001.
Since neutrophils are essential for survival, we investigated if disruption of NLRP6
affects recruitment of neutrophils into alveolar spaces during S. aureus pneumonia. Compared to
WT mice, KO mice had more leukocytes, including neutrophils, and macrophages recruited into
alveolar spaces (Figs 2.3B-D). Furthermore, to measure neutrophil accumulation in the lung
parenchyma, we performed a myeloperoxidase (MPO) assay and that found KO mice had more
MPO activity than WT mice (Fig 2.3E).
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2.3.5 Deletion of NLRP6 enhances bacterial killing of neutrophils through increased IFN-γ
and ROS production.
Since NLRP6 was found to be upregulated in neutrophils and macrophages in the lungs,
we wanted to know whether deletion of NLRP6 affects the function of these cells. To this end,
we compared the intracellular killing ability of bone marrow-derived neutrophils (BMDNs) and
BMDMs isolated from both WT and NLRP6 KO mice following infection with S. aureus
(MOI:10). Our results indicate that neutrophils from NLRP6 KO mice had improved killing
ability compared to WT cells as depicted by the reduction in intracellular CFUs in KO
neutrophils (Fig. 2.4A). It is known that neutrophils use NADPH oxidase-dependent reactive
oxygen species (ROS) to kill S. aureus intracellularly [23-25]. To determine if differences in
killing ability of WT and NLRP6 KO neutrophils is due to an alteration in ROS production, we
compared ROS production by neutrophils from WT and KO mice after infection with S. aureus
and found that KO neutrophils produced more ROS than WT neutrophils (Fig 2.4B). To confirm
these in vitro findings, we assessed the expression of NADPH oxidase components in lung
homogenates from infected mice by western blotting. The expression of p47phox, p67phox, and
gp91phox was increased in the lungs from NLRP6 KO mice compared to those from WT mice,
supporting the finding of higher ROS production by KO neutrophils (Fig 2. 4C). IFN-γ has been
shown to activate phagocytic cells during intra-pulmonary S. aureus infection [26]. Therefore,
we measured the levels of IFN-γ secreted in the BALF of WT and NLRP6 KO mice after
infection with S. aureus. Interestingly, we found that IFN-γ production was higher in KO mice
compared to that of WT mice (Fig 2.4D). The production of IFN-γ requires activation of MAPK
pathways [27]. Accordingly, we found higher MAPK activity in NLRP6 KO lungs than in WT
lungs (Fig 2.4E).
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Figure 2.4. NLRP6-/- neutrophils exhibit enhanced intracellular killing through increased IFN-γ
and NADPH oxidase-dependent ROS production. (A) BMDNs from WT and KO mice were
infected with S. aureus (MOI 10) and the intracellular killing ability of neutrophils was measured
at the indicated time points. (B) ROS production by BMDNs from WT and KO mice were
compared after infection with S. aureus (MOI 1). (C) WT and KO mice (N=6-8/group) were
infected with a sublethal dose of S. aureus (5 X 107 CFU/mouse). At designated time points,
lungs were collected and processed for immunoblotting to compare the expression of NADPH
oxidase enzyme components between WT and KO mice. (D) IFN-γ in BALF obtained from
mice in 3C was measured. (E) Lungs obtained from S. aureus-infected WT and KO mice were
homogenized and expressions of phospho-38, phospho-JNK, and phospho-STAT3 were
measured through immunoblotting. (F) BMDNs from WT and KO mice were isolated and pretreated with either IFN-γ or PBS for 30 minutes before infection with S. aureus (MOI 10). Twohours post-infection, WT neutrophils were lysed and immunoblotted to measure the expression
of NADPH oxidase enzyme components. (G) ROS production by neutrophils in 3F were
measured as described in the methods. All figures are representative of three independent
experiments. ROS: reactive oxygen species, RFU: relative florescence unit. WT: Wild-type,
KO: NLRP6 KO. *, p<0.05, **, p<0.01, and *** p<0.001
IFN-γ has been shown to induce ROS production in human mast cells during
Staphylococcal infection [28]. Based on this observation, we assessed if IFN-γ contributes to the
enhanced bacterial killing by neutrophils through induction of ROS. To this end, BMDNs from
WT and KO mice were pre-treated with IFN-γ and subsequently infected with S. aureus (MOI of
10) followed by assessment of ROS production. Treatment of neutrophils with IFN-γ increased
NADPH oxidase activity and ROS production (Fig 2.4F and G). The activation of phagocytes by
IFN-γ involves activation of signal transducer and activator of transcription (STAT) proteins
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[29]. Supporting this observation, higher expression of phospho-STAT3 was found in the lungs
of KO mice compared to WT (Fig. 2.4E). We also compared intracellular killing ability of
BMDMs, but no difference was observed between WT and KO BMDMs after infection with S.
aureus (Fig 2.4H). Collectively, these results suggest that genetic ablation of NLRP6 increases
bacterial killing by neutrophils through increased IFN-γ and ROS production, which are
associated with higher NADPH oxidase activity.
2.3.6 IFN-γ mediates bacterial clearance in NLRP6 KO mice
We examined if blocking IFN-γ hinders bacterial clearance in the KO mice following
infection with S. aureus. In this context, we administered anti-mouse IFN-γ antibody (100
µg/mouse i.p.) to one group of the KO mice and a similar volume of isotype antibody to another
group of mice 12 hours before infection with S. aureus. Blocking of IFN-γ in the KO mice
increased the bacterial burden in the lungs and BALF suggesting that IFN-γ mediates bacterial
clearance in the KO mice (Fig 2.5A and B).

Figure 2.5. IFN-γ mediates bacterial clearance in NLRP6 KO mice during S. aureus-induced
pneumonia. KO mice (n=6-8/group) were treated with either anti-IFN-γ antibody (100 µg/mouse,
i.p.) or isotype control antibody 12 hours prior to infection with S. aureus (5 X 107 CFU/mouse).
WT mice were treated with equal volume of isotype control antibody 12 hours prior to infection
with S. aureus (5 X 107 CFU/mouse). Twelve-hours post-infection, mice were euthanized to
collect lungs and BALF. Bacterial burden in the (A) lungs, and (B) BALF were compared. All
figures are representative of three independent experiments. *, p<0.05, **, p<0.01, *** p<0.001.
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2.3.7 Natural killer and CD4+T cells are the primary sources of IFN-γ
We next sought to identify the cellular sources of IFN-γ during S. aureus infection. To
this end, we performed flow cytometric analysis of lung cells from WT and KO mice following
infection with S. aureus and found that NLRP6 KO mice had more IFN-γ-positive NK and
CD4+T cells (Fig 2.6A-D).

Figure 2.6. NK cells and CD4+ T cells are the major sources of IFN-γ production during
pulmonary S. aureus infection. WT and KO mice (N=6-8/group) were infected with S. aureus (5
X 107 CFU/mouse). Twelve-hours post-infection, mice were euthanized to harvest lungs. Single
cell suspensions obtained through digestion of lungs were treated with PMA/Ionomycin and
GolgiStop for 5 hours and then stained for flow cytometry. (A) Representative zebra plot
showing CD3- IFN-γ +NK 1.1+ cells. (B) Quantification of A. (C) Representative zebra plot
showing CD3+ IFN-γ+ CD4+T cells. (D) Quantification of C. (E) WT and KO mice (N=68/group) were infected with S. aureus (5 X 107 CFU/mouse). Twenty-four hours post-infection,
mice were euthanized to collect lungs tissues. Single cell suspensions obtained after lung
digestion were stained to estimate NK and CD4 T cells using flowcytometry. The figures shown
above are representatives of three independent experiments. *, p<0.05, **, p<0.01.
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In this regard, Nguyen et al reported NK cells as the major source of IFN-γ during S.
aureus infection [26]. Furthermore, we measured the number of NK and CD4 T cells in the lungs
after infection through flow cytometry and found that the KO mice had more NK and CD4 T
cells accumulated in the lungs compared to that of WT mice (Fig. 2.6E). These results together
suggest that increased IFN-γ observed in the KO mice is due to enhanced numbers of NK and
CD4 T cells recruited during infection. We also found CD8+T cells and γδT cells produce IFN-γ,
although there was no difference between WT and KO mice in the total number of IFN-γpositive CD8 or γδT cells in the lungs (Fig 2.7A-D).

Figure 2.7. Cellular source of IFN-γ in pulmonary MRSA infection. Single cell suspensions
obtained from lungs of S. aureus infected WT and KO mice (N=9-11/group) were stimulated
with PMA/ionomycin along with brefeldin A for 4 hours and then stained intracellularly for IFNγ. (A) Gating strategy to obtain cell positive for both γδT cells and IFN-γ. (B) IFN-γ positive
CD8+T cells. (C) Quantification of A. (D) Quantification of B. (E) NK cells and CD4 T cells (F)
were isolated from WT and KO mice and pre-treated them with MAPK inhibitor (10µM) prior to
infection with S. aureus. Percentage of IFN-γ positive cells are shown. Each figure is a
representative of 3 independent experiments.
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To determine whether increased IFN-γ production in the KO mice is due to higher MAPK
activity in NK and CD4 T cells, we isolated these cells from the lungs of WT and KO mice and treated
them with MAPK inhibitor prior to infection with S. aureus. However, blocking MAPK did not reduce
IFN-γ secretion by NK and CD4 T cells (Figs 2.7E and F).

2.3.8 Deletion of NLRP6 decreases S. aureus-induced pyroptosis and necroptosis
Since we found decreased neutrophil recruitment and increased protein leakage in the
lungs of WT mice compared to KO mice, we hypothesized that cell death in the lungs may be
responsible for these results during S. aureus infection. In this regard, LDH, IL-1α, and HMGB-1
are intracellular molecules released exclusively after cell death and are thus termed alarmins [30,
31]. Therefore, we measured the levels of these alarmins in an in vivo setting and found their
expression to be increased in WT mice compared to NLRP6 KO mice. This suggests that NLRP6
enhances inflammatory modes of cell death during S. aureus-induced pneumonia (Fig 2.8A-C).
We also measured the extent of cell death in BMDNs following infection with S. aureus.
Neutrophils from WT mice exhibited increased cell death, as seen by increased cytotoxicity
(LDH release), compared to that of KO neutrophils (Fig 2.8D). Next, to determine the nature of
cell death, BMDNs from WT and KO mice were pre-treated with either Ac-YVAD-CMK
(Caspase-1 inhibitor) or Necrostatin-1s (Nec-1s, necroptosis inhibitor) and infected with S.
aureus. Pre-treatment of neutrophils with Ac-YVAD-CMK or Nec-1s reduced the cell death in
WT neutrophils suggesting that the nature of cell death is both pyroptosis and necroptosis (Fig.
2.8D). In this regard, it is reported that caspase-1 and gasdermin-D mediate pyroptosis during
bacterial infection [32-34].
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Figure 2.8. NLRP6-/- mice display reduced pyroptosis and necroptosis during S. aureus induced
pneumonia. WT and KO (N=6-8/group/time point) mice were infected with a sublethal dose of S.
aureus (5 X 107 CFU/mouse). (A) LDH released in BALF, (B) IL-1α in BALF, and (C) HMGB1
in serum were measured. (D) BMDNs from WT and KO mice were isolated and pre-treated with
either Ac-YVAD-CMK (100µg/ml), Nec-1s (300 µM), or an equivalent amount of DMSO for 30
minutes prior to infection with S. aureus (MOI 50). Cytotoxicity was measured 2 hours postinfection. (E) Expression of cleaved gasdermin-D in BMDMs obtained from WT and KO mice
after infection with S. aureus for 8 hours. (F) BMDMs from WT and NLRP6 KO mice were
infected with S. aureus (MOI 50) for 8 hours. Caspase-1 activation was observed through
fluorescence microscopy. Caspase-1 positive cells are shown by white arrowheads. (G) BMDMs
from WT and NLRP6 KO mice were infected with S. aureus as in F. Gasdermin-D positive cells
were observed through fluorescence microscopy. (H) Western blots to show expression of
phospho-MLKL, RIP3, RIP1, and cleaved caspase-8 in lungs homogenates obtained from S.
aureus-infected mice. WT and KO mice (N=6-8/group/time-point) were infected with S. aureus.
2 and 24 h post-infection, mice were euthanized to collect lungs and processed for western
blotting. (I) Fluorescent microscopy showing expression of molecules involved in necroptosis in
macrophages after infection with S. aureus. BMDMs obtained from WT and KO mice were
infected with S. aureus (MOI 50) for 8 hours and then stained for phospho-MLKL (red) and
RIP3 (green) antibody. Necroptotic cells are represented as orange (indicated by white
arrowheads). (J) Human pneumonic lungs showing necroptosis. Lungs tissue sections from
healthy and pneumonic patients were deparaffinized and stained with phospho-MLKL, RIP3,
and DAPI. Tissue undergoing necroptosis is shown by white arrowheads. Immunofluorescence
pictures were taken at 40X. All figures are representative of three independent experiments. AcYVAD-CMK: caspase-1 inhibitor, Nec-1s: Necrostatin-1s, CL-GSMD: Cleaved Gasdermin-D,
FL-GSMD: Full-length Gasdermin-D, WT: *, p<0.05, **, p<0.01, and *** p<0.001.
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To validate that NLRP6 induces pyroptosis, we assessed the expression of caspase-1 and
gasdermin-D in BMDMs from WT and NLRP6 KO mice after infection with S. aureus (MOI of
10) for 8 hours. Both cleaved caspase-1 (Fig 2.1F) and gasdermin-D (Fig 2.8E) expression were
higher in WT mice compared to KO mice. Also, we performed immunofluorescence microscopy
on BMDMs to quantify caspase-1 and gasdermin-D expression and found increased caspase-1
and gasdermin-D- positive cells in BMDMs from WT mice compared to NLRP6 KO mice (Figs
2.8F and G).
It has been reported that S. aureus induces pathology in the lungs by a distinct cell death
mechanism known as necroptosis [15]. Receptor-interacting-serine-threonine kinase-1 (RIP1),
RIP3, and mixed lineage kinase-domain like protein (MLKL) are the core protein kinases that
initiate and execute necroptosis [14, 15, 35]. Recently, caspase-8 has been shown to negatively
regulate necroptosis during Salmonella infection in an enteritis model [36]. Thus, to explore
whether NLRP6 can enhance necroptosis in the lungs during S. aureus infection, we assessed the
expression of phospho-MLKL, RIP1, RIP-3, and caspase-8 in lung homogenates obtained from
S. aureus-infected WT and NLRP6 KO mice through western blotting. Interestingly, both
phospho-MLKL and RIP-3 were higher in the lungs of WT mice compared to NLRP6 KO mice
(Fig. 2.8H). To further confirm this finding at the cellular level, we infected both WT and
NLRP6 KO BMDMs with S. aureus for 8 hours and quantified necroptosis using
immunofluorescence microscopy. The immunofluorescence assay also revealed more phosphoMLKL and RIP-3-positive cells in WT macrophages compared to NLRP6 KO macrophages after
S. aureus infection, confirming that NLRP6 increases necroptosis (Fig 2.8I.).
Since S. aureus has been shown to induce necroptosis in human cells, such as THP-1 cell
lines [15], we examined if activation of the necroptosis pathway occurs in lungs of human
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patients during pneumonia. Immunofluorescence microscopy conducted on lung sections
obtained from bacterial pneumonic patients displayed more necroptosis, as evidenced by
increased phospho-MLKL and RIP-3 expression, compared to that of healthy control lungs (Fig.
2.8J).
2.3.9 Blocking pyroptosis and necroptosis in WT mice augments host defense
We found that NLRP6 enhances both pyroptosis and necroptosis pathways during
pulmonary S. aureus infection (Fig. 2.8A-J). Because pyroptosis has been found to be beneficial
for bacterial clearance during intracellular bacterial infections [34], we examined whether
pyroptosis is advantageous during S. aureus infection. Blockade of pyroptosis in mice by intraperitoneal administration of Ac-YVAD-CMK (caspase-1 inhibitor) 12 hours prior to infection
with S. aureus resulted in reduced pulmonary leakage, LDH release, and bacterial burden in
lungs and BALF (Figs 2.9A-D). In addition, blockade of pyroptosis suppressed cytokine
secretion and enhanced survival of WT mice (Figs. 2.9E-H), confirming that pyroptosis is
detrimental during S. aureus infection. It should be noted that the bacterial burden in WT mice
receiving Ac-YVAD-CMK was still high when compared with NLRP6 KO mice (Fig. 2.9C),
suggesting that an NLRP6-dependent, but caspase-1-independent, mechanism also exists to
increase susceptibility to S. aureus infection.
Next, to confirm that NLRP6-mediated necroptosis is detrimental for host defense, we
blocked necroptosis using an MLKL inhibitor (GW806742X) 12 hours before infection with S.
aureus. There was a decrease in total protein and LDH release in the BALF of WT mice treated
with GW806742X, which was comparable to that seen in NRLP6 KO mice (Fig. 2.10A and B).
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Figure 2.9. NLRP6-mediated pyroptosis is detrimental during pulmonary S. aureus
infection. WT and KO mice (N=6-8/group) were administered either Ac-YVAD-CMK (100
µg/mouse) or an equal amount of DMSO 12 hours prior to infection with a sublethal dose of S.
aureus. Caspase-1/11 double knock out mice (N=6-8/group) received an equal amount of DMSO
12 hours prior to infection with a sublethal dose of S. aureus. Mice were euthanized 24 hours
post-infection to collect BALF and lungs. (A) Total protein and (B) LDH release in the lungs,
bacterial burden in (C) lungs and (D) BALF were measured. (E) IL-1β, (F) TNF-α, and (G)
MCP-1 in the BALF were measured through standard ELISA procedure. (H) WT mice
(N=15/group) were treated with either Ac-YVAD-CMK (100 µg/mouse 12 hours prior to
infection with S. aureus), or an equivalent amount of DMSO prior to infection with a lethal dose
of S. aureus (2 X 108 CFU/mouse, i.t.). Survival was monitored up to 80 hours post infection.
Each figure is a representative of at least three independent experiments. Ac-YVAD-CMK:
caspase-1 inhibitor, TNF-α: Tumor necrosis factor-α, MCP-1: Monocyte chemoattractant
protein-1, *, p<0.05, **, p<0.01, *** p<0.001, and **** p<0.0001.
Moreover, blocking necroptosis reduced the bacterial burden in lungs and BALF and
ameliorated the inflammatory cytokine levels in WT mice (Figs. 2.10C-G). Furthermore,
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leukocyte recruitment (neutrophils and macrophages) and survival were also increased in WT
mice treated with necroptosis inhibitor (Figs. 2.10H-K). Collectively, these results reveal that
NLRP6-mediated pyroptosis and necroptosis are detrimental to bacterial clearance and host
survival during pulmonary S. aureus infection

Figure 2.10. Blocking NLRP6-mediated necroptosis in WT mice improves host defense during S.
aureus infection. WT and KO mice (N=6-8/group) were treated with either GW806742X (100 µl
of 100 µM solution, i.p., 12 hours prior to infection) or an equivalent amount of DMSO prior to
infection with a sublethal dose of S. aureus. Mice were euthanized 24 hours post infection to
collect lungs and BALF. (A) Total protein and (B) LDH release in the BALF, bacterial burden in
(C) lungs and (D) BALF were measured. (E) IL-1β, (F) TNF-α, and (G) MCP-1 in the cell-free
BALF were measured. (H) Total leukocytes, (I) neutrophils, and (J) macrophages in the BALF
was determined. (K) WT mice (N=15/group) were treated with either Nec-1s (300 µg/mouse) or
an equivalent amount of DMSO, 18 hours before and at the time of infection with S. aureus
(2X108 CFU/mouse). Survival was monitored for up to 80 hours. Each figure is representative of
three independent experiments. GW806742X: MLKL inhibitor, Nec-1s: Necrostatin-1s. *,
p<0.05, **, p<0.01, and *** p<0.001.
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2.4 Discussion
Lung diseases induced by Gram-positive pathogens are an important cause of morbidity
and mortality in both immunocompetent and immunocompromised individuals [19, 37].
Although antibiotics decrease the morality rates of bacterial pneumonia, the efficacy is
somewhat limited due to the substantial number of immunocompromised individuals, growing
number of elderly patients, and the rise of multi-antibiotic resistant bacterial strains. Thus,
alternative therapeutic approaches, including the manipulation of host signaling events, are
needed. However, detailed understanding of the host innate immune response is critical for the
design of potential therapeutic interventions. Because the lung is continuously exposed to
pathogens and their virulence factors, this organ possesses a multifaceted host defense system.
Moreover, a successful immune response in the lung is critical for efficient clearance of
microbial pathogens and therefore, the innate immune system possess germline-encoded patternrecognition receptors.
The NOD-like receptors (NLRs), including inflammasomes, are specialized cytosolic
pattern-recognition receptors/sensors necessary for clearance of invading cytosolic pathogens.
Under normal homeostatic conditions, the NLRP6 inflammasome is highly expressed in
intestinal epithelial cells [9, 20, 38, 39] where it co-localizes with ASC and caspase-1 [9]. It is
also expressed in immune cells including neutrophils, T-cells, macrophages, and dendritic cells
[7]. Despite high expression of NLRP6 in the lower respiratory tract, the role of NLRP6 in lung
inflammation has not previously been explored. In the current study, we demonstrate that
NLRP6 is upregulated in neutrophils, macrophages, and epithelial cells in the lungs of bacterial
pneumonic patients. Further, NLRP6 is upregulated in myeloid and non-myeloid cells in the

60

lungs and co-localizes with ASC in a mouse model of pulmonary S. aureus infection. We also
found that the important virulence factor, α-hemolysin, can activate the NLRP6 inflammasome.
The immune response to S. aureus is manifested by vascular leakage, neutrophil
recruitment into the alveolar space, and upregulation of cytokines and chemokines [5, 6]. The
current study demonstrates that the NLRP6 inflammasome increases susceptibility to S. aureusinduced lung infection. Delving into the mechanisms underlying this, we found that NLRP6
dampens NK cell-mediated IFN-γ secretion thereby hindering ROS-dependent bacterial clearance
by neutrophils. Moreover, our study identifies NK cells and CD4 T cells as the primary source of
IFN-γ during acute pulmonary S. aureus infection. In agreement with these findings, studies of
Listeria and Salmonella infections [7] have also shown that NLRP6 signaling is detrimental to
host defense. Nonetheless, in a non-infectious model, the NLRP6 inflammasome was found to be
important for epithelial self-renewal, proliferation, and mucus secretion, which were essential for
protection against chemical-induced colitis [9, 38].
Studies from different groups have shown that NLRP6 inflammasome regulates gut
microbiota composition [7, 9, 20]. NLRP6 KO mice were found to have different microbiota
configuration which make them more susceptible to chemical-induced colitis compared to the WT
mice [20]. In contrast, recent studies have demonstrated that NLRP6 and ASC-related
inflammasome do not regulate gut microbiota composition [40, 41]. Although it remains debatable
whether the NLRP6 inflammasome influence gut microbiome, the reported difference in
microflora composition in the KO mice can be nullified by co-housing the mice together with WT
for 4 weeks [7]. In addition to colitis, microbiota have been shown to influence various disease
conditions such as rheumatoid arthritis [42], diabetes [43], inflammatory bowel disease [44], and
colorectal cancer [45]. In our study, however, co-housing of WT with NLRP6 KO mice did not
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change the resistant phenotype of the KO mice against S. aureus. In this context, similar report has
been demonstrated by Anand et al, showing that co-housing does not alter NLRP6 mediated
immune mechanism during Salmonella and Listeria infection [7].
It is widely accepted that hematopoietic and non-hematopoietic (stromal) cells in the lung
produce numerous proinflammatory mediators, including cytokines and chemokines. Although
hematopoietic cells secrete chemokines or neutrophil chemo-attractants, including CXCL1/KC
and CXCL2/MIP-2, the stromal cells (alveolar epithelial cells) secrete other neutrophil chemoattractants, such as CXCL5/LIX and CXCL15/lungkine [46]. Our observations indicate that in
both cell types, NLRP6 contributes to the enhanced susceptibility to S. aureus-induced pneumonia.
These conclusions are consistent with previous studies of the role of hematopoietic and nonhematopoietic cells in the context of bacterial infections in the lungs. In this context, NLRP6 in
both hematopoietic and non-hematopoietic cells increases susceptibility to Listeria and Salmonella
infections [7]. Similarly, CXCL1/KC secreted by both hematopoietic and stromal cells was found
to be crucial for bacterial elimination and neutrophil accumulation in the lungs following
Klebsiella pneumoniae infection [47]. Nevertheless, it is clear from this investigation that
neutrophil accumulation and function are critical for host protection against S. aureus.
Pyroptosis and necroptosis are two distinct inflammatory modes of cell death. While
pyroptosis is mediated by caspase-1 [32-34] and executed by gasdermin-D [32, 33], necroptosis
is regulated by RIP1, RIP3, and MLKL (caspase-1 independent) [15, 35]. Pyroptosis has been
shown to play an essential role in limiting several intracellular bacterial infections such
Salmonella typhimurium, Legionella pneumophila, and Burkholderia thailandensis [34].
However, extensive caspase-1 activation and subsequent pyroptosis have also been associated
with the severity of several diseases such as myocardial infarction [48], inflammatory bowel
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disease [49], and endotoxic shock [50]. Pertaining to these observations, we report that during S.
aureus infection, NLRP6-mediated pyroptosis is detrimental for host survival. Furthermore,
blocking pyroptosis reduced the hyper-inflammatory milieu and subsequently increased survival
suggesting that pyroptosis triggers exaggerated inflammation during S. aureus infection. This
difference in the role of pyroptosis can be attributed to differences in pathogenic properties and
lifestyles of bacterial pathogens. While S. aureus is predominantly an extracellular pathogen,
studies have shown that it can also survive intracellularly [51] and can resist anaerobic
conditions [52]. Necroptosis induced by S. aureus is responsible for pathology in the lung [15];
however, its relationship with inflammasomes was previously unknown. Although ASC and
NLRP3 have been linked with pore-forming toxin-induced necroptosis [14], the precise role of
inflammasomes in the induction of necroptosis is not clear. In this study, we used both in vivo
and in vitro experiments to show that NLRP6 mediates necroptosis of immune cells during acute
pulmonary S. aureus infection. Moreover, S. aureus exploits NLRP6 to drive necroptosis, which
is accompanied by an intense inflammatory response and loss of macrophages and neutrophils. It
is possible that reduced cell death in NLPR6 KO mice attributed to higher leukocyte
accumulation in the lungs of these mice. Since TNF-α has been shown to induce necroptosis [53,
54], the reduction of TNF-α found in the NLRP6 KO mice suggests that NLRP6 can trigger
necroptosis via the TNF-α pathway. However, more comprehensive future studies will be needed
to identify the detailed molecular mechanisms underlying NLRP6-mediated necroptosis. Future
studies are also needed to determine whether other toxins or virulence factors produced by S.
aureus can also activate the NLRP6 inflammasome.
In conclusion, the present study reveals the detrimental role of NLRP6 during S. aureus
pneumonia (S6 Fig). Further, NLRP6 in both hematopoietic and resident lung compartments
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contribute to S. aureus-induced lung inflammation. Not only does NLRP6 subdue neutrophil
function by dampening IFN-γ and ROS production, it also triggers pyroptosis and necroptosis in
the lungs that may lead to hyper-inflammation, loss of neutrophils, and mortality. However, future
studies are essential to determine whether NLRP6 interacts with other inflammasomes such as
NLRP3 and/or NLRC4 to induce pyroptosis and necroptosis during S. aureus infection.
Comprehensive studies using specific double- or triple-KO mice would be useful to delineate these
interactions in a conclusive manner. Further, extending upon our findings, we propose that
functional single nucleotide polymorphisms in human NLRP6 may have effects on host defense
mechanisms against gram-positive microbes.
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CHAPTER 3. NLRP6-DERIVED IL-18 ENHANCES MORTALITY DURING
POLYMICROBIAL SEPSIS
3.1 Introduction
Sepsis is a leading cause of death in intensive care units (ICU) [1] and the most expensive
disease as it accounted for more than $20 billion hospital expenses in 2011 [2].The third
consensus conference has defined sepsis as “a life-threatening organ dysfunction caused by a
dysregulated host response to infection” [1]. The estimated annual incidence of sepsis is around
19 million worldwide [3] and the incidence is increasing due to increased number of
immunocompromised patients and improvement in identification of septic patients [1].
Numerous clinical trials have been performed in past 20 years; however, none of these trials
succeed to provide an effective drug that could be used to treat the sepsis patients. In this
situation, research to understand the detailed pathophysiology of sepsis is warranted in order to
identify potential new drug targets of treatment strategies.
Pattern recognition receptors like Toll-like receptors (TLRs) and Nod-like receptors
(NLRs) are germline encoded innate immune components which play important roles in
initiating the innate immune response to infections. Unlike TLRs, certain NLRs have ability to
bind with an adaptor molecule like ASC (Apoptosis-associated speck-like protein containing
CARD) and recruit an enzyme called caspase-1 to form a multiprotein complex known as
inflammasome [4]. The active caspase-1 cleaves inactive form of IL-1β and IL-18 to their active
form in order to initiate immune responses [4, 5]. While the roles of TLRs (especially TLR2,
TLR3, TLR4, and TLR9) [6-9] in the outcome of sepsis are well defined, very few studies [10,
11] have focused to determine the roles of different NLRs in the pathophysiology of sepsis.
NLRP6 is a relatively new member of NLR family which is shown to form
inflammasome during both infectious [12, 13] and non-infectious conditions [14]. In a recent
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study using mouse model of pulmonary S. aureus infection, NLRP6 inflammasome was found to
negatively regulate neutrophil-dependent host immunity [12]. Similar negative roles of NLRP6
were also reported during other bacterial infections such as Salmonella and Listeria [13, 15].
However, a study using an enteric pathogen, Citrobacter rodentium, NLRP6 inflammasome was
found to be important for host defense [16]. Similarly, during viral infection, NLRP6 KO mice
showed increased viral burden in the intestine compared to their WT counterparts [17]. These
observations suggest that the role of NLRP6 inflammasome could be model or pathogen specific.
Although NLRP6 is well expressed in the intestines, kidneys, liver, and lungs [18], its potential
roles in sepsis remain elusive.
Using mouse model of CLP-induced polymicrobial sepsis, we demonstrate for the first
time that NLRP6 inflammasome is detrimental during sepsis. NLRP6-driven IL-18 elicits
hyperinflammation, lymphocytic cell death, and mortality. In addition, NLRP6 suppresses IFN-γ
production by both CD4 and CD8 T cells. These results suggest that NLRP6 inflammasome
serves as a negative regulator of host protection during polymicrobial sepsis.
3.2 Methods
3.2.1 Mice. C57BL/6 (wild type) mice were purchased from Jackson Laboratories (Bar Harbor,
ME). NLRP6-/- and IL-18 KO-/- mice were purchased from the Millennium Pharmaceuticals
(Cambridge, MA) and then backcrossed 10 times with C57BL/6 mice. Animals were kept in
specific pathogens free environment with access to food and water all the time. All animal
experiments were performed in accordance with the Guide for the Care and Use of Laboratory
Animals of the National Institute of Health. The animal protocol (16-028) was approved by
Institutional Animal Care and Use Committee (IACUC) at Louisiana State University.
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3.2.2 Human tissue samples. Human splenic tissue blocks (septic and non-septic) were kindly
granted by Dr. Richard S Hotchkiss, Washington University School of Medicine at St. Louis,
MO.
3.2.3 Induction of sepsis. Sepsis was induced in mice using CLP technique as described in our
previous publication [11]. It is further discussed in detail in supplemental section. For single
bacterium induced sepsis, we injected E. coli at the dose rate of 5 X 108 CFU/kg of mouse intraperitoneally and observed the survival for next 12 days. Recombinant IL-18 was administered
immediately after CLP (5 ug/mouse, IP) [48]. For IL-18 blocking, mice received 200 µg of antiIL-18 antibody (BioXcell, NH) 12 and 2 hours prior to induction of CLP. CD4 or CD8 T cells
were depleted by treating each mouse with 200 µg of anti-CD4 or anti-CD8 antibody (BioXcell,
NH) 12 and 2 hours prior to CLP surgery.
3.2.4 Collection of peritoneal lavage fluid. After specific time points, mice were euthanized.
The peritoneal cavity was washed by injecting 7 ml of PBS containing heparin and dextrose. The
lavage fluid was collected in a sterile conical tube. A total of 6ml of lavage fluid was collected
from each mouse. The total and differential leukocyte count was performed in the peritoneal
fluid as described in our previous publication [12].
3.2.5 Flow cytometry. Flowcytometric staining was performed as recommended by
manufacturer’s protocol (BioLegend, San Diego, CA). The single cell suspensions obtained from
septic WT and NLRP6 KO mice were stained with antibody against CD3ε (145-2C11), CD4
(GK1.5), CD8α (53-6.7), T-bet (4B10), IFN-γ (XMG1.2) (BioLegend, San Diego, CA), and PI
(Thermo Fisher Scientific, Waltham, MA). The stained cells were fixed with 2%
paraformaldehyde and analyzed using either a FACs Caliber or LSRFortessaX20 (BD).
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Appropriate isotype antibodies were used each color. The data obtained were analyzed using
FlowJo_V10 (Treestar).
3.2.6 Western blotting. Western blotting was performed as described previously. Briefly,
spleens from septic mice were homogenized with beads in the presence of protease/phosphatase
inhibitor cocktail. Equal amount of protein from each spleen sample was loaded on to 10% SDSPAGE gel. The proteins were then transferred to polyvinylidene fluoride membrane. Primary
antibodies against mouse cleaved caspase-3, caspase-7, RIP-3, MLKL, gasdermin-D, and BCL2
were added to the membrane and incubated for overnight at 40 C. Next day, appropriated
secondary antibodies were added, and films were developed using ECL plus western blot
detection system.
3.2.7 Immunofluorescence assay. Parafilm-embedded splenic tissue blocks from septic and
non-septic patients were provided by Dr. Richard S Hotchkiss, Washington University School of
Medicine at St. Louis, MO. Immunofluorescence assay was performed in spleen tissue section
from human patients and mice as described in our previous publication [12]. The following
primary antibodies were used: human NLRP6, CD3, CD4, CD8 and mice NLRP6, CD3, CD4,
and CD8. After overnight incubation with these primary antibodies, the excess antibodies were
washed off with cold PBS. The slides were then stained with appropriate secondary antibodies
against human and mouse antigens for 30 minutes at room temperature. Image were taken under
florescent microscope (Zeiss Axioskop 2 Plus microscope.
3.2.8 In vivo BrdU incorporation. BrdU incorporation experiment was performed in accordance
with the manufacturer’s recommendations (BD Biosciences). Briefly, WT and KO mice were
treated with BrdU (1mg/mouse, i.p.) immediately after CLP. At designated time point, mice were
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euthanized to collect splenic cells and stained with fluorescently labelled antibodies including
BrdU. The data were acquired using an LSRFortessaX20 (BD).
3.2.9 Cytokine measurement. Cytokines were measured using standard ELISA procedure as
described in manufacturer’s protocol (ebioscience/Thermofisher scientific, MA).
3.2.10 Cell death assay. Measurement of cell death was performed using Cytox-One
Homogenous Membrane Integrity Assay Kit (Promega, WI) following the manufacturer’s
protocol. LDH release was expressed in relative fluorescence units (RFU).
3.2.11 Statistics. Data are presented as Mean ± SEM. Unpaired two-tailed students t test was
used to compare the data between two groups. One-way ANOVA followed by Tukey’s multiple
comparisons test was used whenever there were more than two groups. Survival analysis was
performed using Log-rank test. P value less than 0.05 was considered significant.

3.3 Results
3.3.1 NLRP6 is upregulated in the spleens of septic patients and CLP-induced septic mice
To determine whether NLRP6 is upregulated in the spleen of human patients, we
obtained spleen tissue sections from septic and non-septic patients and performed
immunofluorescence assay to determine the upregulation of NLRP6 in these tissue sections.
Interestingly, NLRP6 (Red) was upregulated in CD3, CD4, and CD8 T cells (Green) of septic
patients compared to that of non-septic patients (Figure 3.1 A). Consistent with this finding,
NLRP6 (Red) was also upregulated in splenic CD3, CD4, and CD8 T cells (Green) of CLPinduced septic mice compared to sham-operated mice (Figure 3.1 B).
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Figure 3.1: Expression of NLRP6 in lymphocytes of septic human patients and septic mice. A)
Tissue section from septic and non-septic patients were processed for immunofluorescence
assay. Tissue was stained against anti-human CD3, CD4, CD8 T cells (Green), anti-human
NLRP6 (Red), and DAPI (Blue). The white arrowheads represent NLRP6+ cells. B) C57BL/6
wild type (WT) were either subjected to CLP or sham surgery. Twenty-four hours post-CLP,
mice were euthanized to collect spleen for histopathological processing. Paraffin embedded
spleen sections were processed for immunofluorescence microscopy. Antibodies used were antimouse CD3, CD4, CD8 T cells (Green), anti-mouse NLRP6 (Red), and DAPI (Blue). The white
arrowheads represent NLRP6+ cells. Each image is a representative image from 4 different fields
from 3 independent experiments. Magnification: 40X.

3.3.2 NLRP6 deficiency confers host protection during murine model of sepsis
To investigate the role of NLRP6 in polymicrobial sepsis, we induced moderate sepsis in
NLRP6 KO and WT mice through CLP technique and observed the survival for 10 days.
Interestingly, the KO mice had better survival (80% vs 40%) compared to that of WT mice
(Figure 3.2A). To determine whether the resistant phenotype in the KO mice is model specific,
we infected KO and WT mice with sub-lethal dose of E. coli intraperitoneally and observed the
survival for 10 days. Consistent with the CLP model, the KO mice had improved survival
compared to that of WT mice during E coli-induced sepsis (Figure 3.2B). Furthermore, we
measured bacterial burden in major organs and peritoneal lavage fluid (PF) after inducing sepsis
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through CLP. The KO mice had less bacteria in the PF, spleen, and kidney compared to that of
WT mice at both 12- and 24-hours post-CLP (Figures 3.2C-E). NLRP6 inflammasome has been
implicated in regulating gut microbiota composition [15, 16]. To determine whether differences
in gut microbiota can influence outcome of sepsis, we co-housed WT and KO mice for 4 weeks
and induced sepsis through CLP technique. The co-housed KO mice still had less bacterial
burden in the PF, spleen, and Kidneys compared to that of WT mice suggesting that the
phenotype observed in the KO mice is not microbiota dependent (Figures 3.2F-H).
3.3.3 NLRP6 mediates hyperinflammation during polymicrobial sepsis
Sepsis is characterized by initial hyper inflammatory phase followed by prolonged hypoinflammatory or immunosuppressive stage [19, 20]. Both these phases are implicated for death
of septic patients. Therefore, we determined whether NLRP6 initiates hyperinflammation to
enhance mortality during sepsis. To this end, we induced sepsis through CLP and measured
inflammatory cell recruitment in the PF. Interestingly, WT mice had more total WBCs and
neutrophils recruited in the peritoneal cavity compared to that of KO mice after sepsis (Figure
3.3A). In addition, we measured major proinflammatory cytokines in the cell free PF obtained
from septic mice. The WT mice had massive cytokine storm as seen by increased levels of IL-1β,
TNF-α, MCP-1, and CXCL1 compared to that of KO mice (Figures 3.3B-E). Reduction in IL-1β
in the PF of KO mice compared to WT mice indicates that NLRP6 inflammasome is activated
during sepsis. Moreover, IL-10, which is considered as a predictive of fatal outcome in sepsis
[21, 22], was also more abundant in WT compared to that of KO at 24 hours post-CLP (Figure
3.3F).
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Figure 3.2. The impact of NLRP6 in host protection in a murine model of sepsis. A) C57BL/6
wild-type (WT) and NLRP6 KO mice (N=14 per group) were subjected to CLP-induced
polymicrobial sepsis and survival was monitored for 12 consecutive days. The curve shown is a
representative figure of 3 independent experiment (N=14-16 per group each time). Data analyzed
using Log-rank (Mantel-Cox) test (*P<0.05). B) WT and NLRP6 KO mice (N=10 per group)
were injected with 107 CFUs of E coli per mouse intraperitoneally (IP) and monitored for 12
days post-infection. The figure shown is a representative of 3 independent experiments (N=10
per group each time). Log-rank (Mantel-Cox) test was used to analyze the data (*P<0.05). C-E)
WT and KO mice (N=6-10 per group) were subjected to CLP-induced polymicrobial sepsis.
Sham operated animals were used as control. Twelve- and 24-hours post infection, mice were
sacrificed to collect peritoneal lavage fluid (PF), spleen, and kidneys for estimating bacterial
burden. Each figure is a representative figure of 3 independent experiments. Data were analyzed
using unpaired two-tailed student’s t test for each time points (*P<0.05, **P<0.01, and
***P<0.001). F-H) WT and NLRP6 KO mice (N=5 per group) were co-housed for 4 weeks and
induced polymicrobial sepsis via CLP. Twenty-four hours post-CLP, mice were euthanized to
enumerate bacterial burden in PF, spleen, and kidneys. Data represented as Mean ± SEM. Each
scatter plot is a representative figure of 3 independent experiments. Data were analyzed as
described for C-E.
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Figure 3.3. Role of NLRP6 in inflammation during polymicrobial sepsis. A) CLP- and sham
operated WT and NLRP6 KO mice (N=6-10 per group) were euthanized at designated time
points to collect PF. Total and differential cell counting were performed in PF using Diff-Quik
staining and light microscopy. The figure displayed is a representative figure of 3 independent
experiments. Data analyzed using Multiple t test: one per row (*P<0.01). B) IL-1β, C) TNF-α,
D) MCP-1, E) CXCL-1, and F) IL-10 were measured in PF using standard ELISA procedure. All
data represented as Mean ± SEM. Each bar-diagram is a representative figure of 3 independent
experiments. Data analyzed using unpaired two-tailed student’s t test for each time points
(*P<0.05 and **P<0.01). CLP=Cecal ligation and puncture, PF=Peritoneal lavage fluid, IL1β=Interleukin-beta, TNF-ἀ=Tumor necrosis factor-alpha, MCP-1=Monocyte chemoattractant
protein-1, CXCL-1=C-X-C motif chemokine ligand 1, and IL-10=Interleukin-10.

3.3.4 NLRP6 augments sepsis-induced lymphocytic cell death in the spleen
Sepsis causes extensive loss of T-cells in the spleen that leads to immunosuppression and
mortality [19, 23, 24]. Based on this fact, we determined whether NLRP6 inflammasome
enhances lymphocyte death during sepsis. For this, we first measured the number of T cells in
the spleen after inducing sepsis and found that the WT mice had less CD3 positive lymphocytes
compared to that of KO counterparts (Figures 3. 4A and B). Interestingly, the normal CD4 to
CD8 T cells ratio (2:1) observed in sham animals was reduced to 1:1 in both WT and KO mice
after sepsis suggesting that sepsis alters the proportion of CD4 and CD8 T cells in the spleen
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Figure 3.4: NLRP6 augments sepsis-induced lymphocytic cell death in the spleen. WT and
NLRP6 KO mice (N=6-8 per group) were subjected to CLP-induced polymicrobial sepsis. At
designated time points, mice were sacrificed to collect spleen. The single cell suspensions
obtained from septic and sham spleen were stained with appropriated fluorochrome-tagged
antibodies and subjected to flowcytometric analysis. A) A representative pseudo-color plot
showing total CD3+ T cells. B) Quantification of A. C) Representative figure showing the
proportion of CD4 and CD8 T cells within CD3 cells. D) Quantification of C. E) A
flowcytometric figure showing CD3+CD4+ T cells. F) Quantification of E. G) A representative
flowcytometric figure displaying CD+CD8+ T cells. H) Quantification of G. I) A representative
zebra plot showing PI+CD3+ T cells. J) Quantification of I. All bar diagrams are expressed as
Mean ± SEM. Each figure is a representative figure of 3 independent experiments. Figure B, F,
H, and J were analyzed using unpaired two-tailed student’s t test (*P<0.05, and ***P<.001). K)
LDH release in the PF obtained from septic WT and KO mice (N=6-8 per group) was measured
using LDH assay kit. Data expressed as Mean ± SEM. The graph is a representative graph of 3
independent experiments. Unpaired two-tailed student’s t test was used to analyze the data
(*P<0.05). LDH=Lactate dehydrogenase.

(Figures 3.4C and D). Similar observation was reported from the blood of septic patients [25].
The number of CD4 T cells significantly reduced after sepsis in both WT and KO mice;
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however, this reduction was less pronounced in the KO mice (Figure 3.4E and F). In contrast, the
number of CD8 T cells increased in both WT and KO mice after sepsis; however, the increase
was more pronounced in KO compared to that of WT counterparts (Figure 3.4G and H). The
increased numbers of CD4 and CD8 T cells observed in the spleens of KO mice could be due to
reduced cell death and/or increased proliferation. To this end, we induced sepsis in WT and KO
mice and measured the extent of cell death in the spleen through flowcytometry. Interestingly,
WT mice had significantly more PI+ T cells compared to that of KO mice (Figs. 3.4I and J). In
addition, the PF obtained from septic KO mice displayed less LDH compared to that of WT
counterparts confirming that NLRP6 enhances cell death during sepsis (Fig. 3.4K). Next, to
determine whether NLRP6 affect the proliferation of T cells in the spleen during sepsis, we
measured BrdU+ T cells after inducing CLP and found that KO mice had more BrdU+ cells in the
spleen (Fig. 3.5).
3.3.5 NLRP6-mediated increased susceptibility to polymicrobial sepsis is IL-18 dependent.
IL-18 and IL-1β have been implicated for aggravating septic conditions [26-31]. Based
on this fact, we measured levels of IL-18 and IL-1β in PF of WT and KO mice and found that
these cytokines were less abundant in KO mice compared to that of WT mice (Figs 3.6A and B).
Moreover, we hypothesized that reduced IL-18 and/or IL-1β in the KO mice could account for
higher survival in these mice. To this end, we administered recombinant IL-1β or IL-18 to the
KO mice (IP) immediately after CLP and observed the survival. Treatment with IL-18 reversed
the survival advantage observed in the KO mice following sepsis. However, no difference in the
survival was observed in WT mice upon IL-β treatment suggesting that NLRP6 increases
susceptibility via IL-18 (Fig. 3.6B).
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Figure 3.5: Role of NLRP6 deficiency in the proliferation of CD4 and CD8 T cells in the spleen
during sepsis. WT and NLRP6 KO mice (N=6-8 per group) were subjected to CLP surgery to
induce polymicrobial sepsis. BrdU was injected right after CLP procedure. Single cell
suspensions obtained from septic mice were stained to obtain BrdU positive cells. A) Percentage
of BrdU+ CD3 T cells. B) Quantification of A. C) Percentage of BrdU+ CD4 T cells. D)
Quantification of C. E) Percentage of BrdU+ CD8 T cells. F) Quantification of E. The
experiment was repeated thrice. Data in bar diagram are expressed as Mean ± SEM. Data
analyzed using unpaired two-tailed student t test (*P<0.05).

3.3.6 NLRP6-driven IL-18 enhances destructive inflammation during polymicrobial sepsis.
Next, we sought to determine the mechanism how IL-18 enhances mortality in NLRP6
KO mice following sepsis. Since NLRP6 KO mice displayed attenuated inflammation and less T
cell death, we hypothesized that IL-18 could contribute to hyperinflammation and high
lymphocyte loss in the WT mice ultimately leading to mortality. To this end, we administered
recombinant IL-18 in the KO mice immediately after sepsis and determined the extent of
inflammation. Interestingly, mice that received IL-18 had higher levels of inflammatory
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cytokines such as IL-6, TNF-α, MCP-1, and CXCL1 compared to the groups that didn’t receive
IL-18 (Figs. 3.7A-D). In addition, we measured the extent of cell death by determining the levels
of cell death alarmins (LDH and IL-1α) [12] in the PF after administration of IL-18.

Fig. 3.6: NLRP6-mediated increased susceptibility to polymicrobial sepsis is IL-18 dependent.
A) Polymicrobial sepsis was induced in WT and NLRP6 KO mice (N=6-8 per group) using CLP
technique. At designated time points, mice were humanly euthanized to collect PF. IL-18 in cell
free PF supernatants was measured using ELISA. The figure is a representative of 3 independent
experiments. Data expressed as Mean ± SEM and analyzed using unpaired two-tailed student’s t
test (*P<0.05). B) WT and NLRP6 KO mice (N=10 per group) were subjected to CLP-induced
polymicrobial sepsis. WT mice received PBS right after CLP whereas, NLRP6 KO mice either
received PBS, IL-18, or IL-1β immediately after CLP surgery. Survival was monitored for next
10 days. The experiment was repeated 3 times (N=10 per group each). The survival analysis was
performed using Log-rank (Mantel-Cox) test (*P<0.05).

Interestingly, the KO group that received IL-18 had more cell death compared to that of
WT mice (Figs 3.7E and F). Since NLRP6 KO mice had less cell death, we measured the T cells
population in the spleen after induction of sepsis. Intriguingly, the KO mice that received IL-18
had less CD3+ T cells in the spleen compared to the group that received PBS only (Figure 3.7G
and H). To confirm this finding, we used IL-18 KO mice and observed more T cells in the spleen
compared to that of WT after sepsis (Fig. 3.8A). We further examined CD4 and CD8 T cells
within the T cells population and found that IL-18 specifically led to depletion of CD8 T cells in
the spleen of NLRP6 KO mice during polymicrobial sepsis (Figs. 3.7I and J). However, no
change in CD4 T cells population was observed after IL-18 treatment (Figs 3.8B and C)
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suggesting that IL-18 does not affect CD4 T cell death during murine model of polymicrobial
sepsis.

Figure 3.7: NLRP6 inflammasome driven IL-18 enhances inflammation and CD8 T cell
depletion during polymicrobial sepsis. We induced sepsis in WT and NLRP6 KO mice (N=6-8
per group) through CLP procedure. WT mice received PBS whereas the KO mice either received
PBS or IL-18. At 36 hours post-CLP, mice were sacrificed to collect PF. A) IL-6, B) TNF-ἀ, C)
CXCL1, and D) MCP-1 were measured in the PF using ELISA procedure. E) LDH released in
the PF was measured using Fluorimetric kit. F) IL-1α was measured in PF using ELISA
procedure. Each figure is a representative figure of 3 independent experiments. Data are
expressed as Mean ± SEM in each bar diagram. Data from A-F were analyzed using one-way
ANOVA followed by Tukey’s multiple comparisons test (*P<0.05, and **P<0.01). G-J) Spleens
obtained from mice in A were processed to generate single cell suspensions. These cells were
then stained with antibodies to estimate the numbers of T cells subpopulations using
flowcytometry. G) Representative plot showing percentage of CD3+ T cells. H) Absolute
numbers of T cells per 300,000 events. I) Representative plot displaying percentage of CD3+
CD8+ T cells. J) Absolute numbers of CD3+ CD8+ T cells per 300,000 events. Data are
represented as Mean ± SEM. Each figure is a representative of 3 independent experiments.
Figures H and I are analyzed using one-way ANOVA followed by Tukey’s multiple comparisons
test (*P<0.05 and **P<0.01).
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Figure 3.8: Effect of IL-18 on lymphocyte population during sepsis. A) We induced sepsis in
WT and IL-18 KO mice (N=5 per group) through CLP technique. At 36 hours post-CLP, spleens
were collected to obtain cell suspensions. These cells were then stained with to analyze total
CD3+ T cells through flowcytometry. The figure is representative of 3 independent experiments.
Unpaired two-tailed student t test was used to analyze the data (*P<0.05). B-C) We used WT and
NLRP6 KO mice (N=6-8 per group) and induce sepsis through CLP procedure. WT mice
received PBS whereas the KO mice either received PBS or IL-18. At 36 hours post-CLP, mice
were sacrificed to estimate CD4 T cells population within spleen through flowcytometry.
Experiment was repeated thrice. Data in the bar graphs are represented as Mean ± SEM. Oneway ANOVA followed by Tukey’s multiple comparison tests was used to analyze the data
(*P<0.05).

3.3.7 CD8 T cells but not CD4 mediates bacterial clearance during sepsis
Since CD4 and CD8 T cells were higher in NLRP6 KO mice compared to that of WT
counterparts, we sought to determine their roles in bacterial clearance during polymicrobial
sepsis. In this regard, we depleted CD4 and CD8 cells by using specific antibodies. Although
depletion of CD4 T cells did not affect bacterial clearance during polymicrobial sepsis (Figs.
3.9A and B), depletion of CD8 T cells increased bacterial burden in the PF and spleen in the KO
mice (Figs. 3.9C and D).
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Figure 3.9: Role of CD8 T cells in host protection during polymicrobial sepsis. A and B) WT and
NLRP6 KO mice (N=5/group) were either treated with either isotype antibody or anti-CD4
antibody prior to induction of CLP. Twenty-four hours post-CLP, mice were euthanized to
measure bacterial burden in A) peritoneal fluid (PF) and B) Spleen. C and D) Mice from WT and
NLRP6 KO group (N=5/group) were administered with either isotype or anti-CD8 antibody
before induction of sepsis. After 24 hours, bacterial loads in A) PF and B) spleen were measured.
Data in each graph are represented as Mean ± SEM. Each graph is a representative graph of 3
independent experiments. Data analyzed using one-way ANOVA followed by Tukey’s multiple
comparison test (*P<0.05 and **P<0.01).

3.3.8 NLRP6 suppresses T cells mediated IFN-γ production via regulating T-bet expression
during sepsis
Since NLRP6 was found to affect T cells survival and proliferation, we were interested to
investigate whether it can modulate T cell function during sepsis. Several studies have reported
critical role of IFN-γ in sepsis [32-34] and reduced ability of septic lymphocytes to produce this
cytokine is an indication of immunosuppression [34]. To determine whether NLRP6 affects
IFN-γ production, we determined the level of this Th-1 specific cytokine after inducing sepsis
and found that KO mice had more IFN-γ in the peritoneal fluid compared to that of WT mice
(Fig. 3.10A). Since T cells are an important source of IFN-γ production, we compared IFN-γ
produced by these cells in WT and KO mice after induction of sepsis. Consistent with the result
in PF, the KO mice had more IFN-γ positive CD4- and CD8 T cells compared to WT mice
suggesting that NLRP6 not only affects T cells survival, it also impairs T cell function (Figures
3.10B-E).
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Figure 3.10: NLRP6 suppresses T cells mediated IFN-γ production via regulating T-bet
expression during sepsis. A) IFN-γ was measured in PF obtained from CLP-induced septic WT
and NLRP6 KO mice (N=6-10 per group). B-E) Spleens obtained from septic WT and NLRP6
KO mice (N=6-8 per group) were processed to obtain single cell suspensions. The cells were
then stimulated with leukocyte activation cocktail for 4 hours and intracellularly stained to
enumerate IFN-γ producing T cell populations. A total of 250,000 events were collected. B)
Zebra plot showing percentage of IFN-γ+CD4 T cells within CD3+CD4+ T cells. C)
Quantification of B. D) A representative zebra plot showing IFN-γ+CD8 T cells within
CD3+CD8+ T cells. E) Quantification of D. F-I) Single cells suspensions obtained from spleens
of CLP-induced septic WT and NLRP6 KO mice (N=6-8 per group) were stained with
appropriate antibodies to analyze the expression of T-bet within CD4 and CD8 T cells. F) A
representative flowcytometric plot showing percentage of T-bet+CD4 T cells within CD3+CD4+
T cells. G) Quantification of F. H) A representative zebra plot showing T-bet+CD8 T cells within
CD3+CD8+ T cells. I) Quantification of H. Each figure is a representative of 3 independent
experiments. Data represented as Mean ± SEM. Bar diagrams A, C, E, G, and I were analyzed
using unpaired two-tailed student’s t test (*P<0.05, and **P<0.01). PF=Peritoneal fluid.
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Next, we determined how NLRP6 suppresses IFN-γ secretion by T cells. Studies have
shown that IFN-γ secretion by T cells is regulated by T-bet expression [35-37]. T-bet directly
activates Ifng that encodes for IFN-γ [35]. Based on these observations, we determined whether
NLRP6 regulates T-bet expression to modulate IFN-γ secretion. For this, we compared the
expression of T-bet on splenic CD4 and CD8 T cells from WT and KO mice after sepsis and
found that the KO mice had more T-bet expressed on CD4 and CD8 compared with their WT
counterparts (Figs. 3.10F-I).

3.3.9 Blocking IL-18 in WT mice reduces cytokine storm, bacterial burden, and improves
survival during polymicrobial sepsis
Since NLRP6-mediated host susceptibility to polymicrobial was IL-18 dependent, we
determined whether blockage of IL-18 in the WT mice could improve the outcome of sepsis in
the WT mice. For this, we neutralized IL-18 in the WT mice by using anti-IL-18 antibody,
induced sepsis through CLP method, measured inflammatory cytokines, and enumerated
bacterial burden in the PF, liver, and spleen. As observed in NLRP6 KO mice, WT mice that
received blocking antibody showed attenuated cytokines production and cell death (Figs. 3.11AE). Furthermore, bacterial burden in PF and spleen were significantly reduced after neutralizing
IL-18 (Figs. 3.11F and G). Finally, blocking IL-18 enhanced the survival in the WT mice
suggesting that IL-18 is indeed, detrimental during polymicrobial sepsis (Figure3.11H).
Consistent with our findings, IL-18 was found to enhance lung inflammation and bacterial
burden in murine model of Pseudomonas aeruginosa infection [38].
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Figure 3.11: Blocking IL-18 in WT mice reduces cytokine storm, bacterial burden, and improves
survival during polymicrobial sepsis. WT and NLRP6 KO mice (N=5 per group) were subjected
to CLP-induced polymicrobial sepsis. WT mice received either IgG1 or anti-IL-18 antibody at 12
and 2 hours prior to CLP whereas KO mice received IgG1 at those time points. A) TNF-α, B) IL6, C) MCP-1, D) CXCL1, and E) LDH release in the PF were determined. Bacterial burden in F)
Peritoneal fluid and G) Spleen was enumerated. All data are represented as Mean ± SEM. Each
figure is a representative figure of 3 independent experiments. Data in figure A-G were analyzed
using one-way ANOVA followed by Tukey’s multiple comparisons test (*P<0.05 and
**P<0.01). H) WT mice (N=10 per group) received either IgG1 or IL-18 antibody and NLRP6
KO mice (N=10 per group) received isotype antibody 12 and 2 hours prior to CLP surgery.
Survival was monitored for next 12 days. The experiment was repeated thrice (N=10 per group
each time). Data analyzed using Log-rank (Mantel-Cox) test (*P<0.05). PF=Peritoneal fluid.

3.4 Discussion
Sepsis is a complex disorder characterized by initial hyperinflammatory response
followed by immunosuppressive stage both of which contribute to mortality. However, the
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mechanism behind the initiation of exaggerated inflammation and subsequent
immunosuppression remains elusive. Through this investigation, we have demonstrated that
NLRP6 is upregulated in different lymphocytic cells of septic patients and septic mice. NLRP6
inflammasome triggers destructive inflammatory response and enhances sepsis-induced
immunosuppression through increased loss of T cells and reduced IFN-γ production. In addition,
we have shown that NLRP6-driven IL-18 enhances mortality in sepsis through mediating both
inflammation and cell death.
Using CLP-induced polymicrobial sepsis and E. coli-induced septic shock, we have
confirmed that NLRP6 KO mice are protected from sepsis. In line with our findings, negative
roles of NLRP6 inflammasome have been reported from other infection models including
pulmonary [12] and systemic bacterial infections [13, 15]. Similarly, we and others have
demonstrated detrimental roles of NLRP3 inflammasome during sepsis [10, 11]. Although these
models have similar phenotypes, the mechanisms associated with these findings are model
specific. In systemic bacterial infection model, NLRP6 was found to regulate MAPK and
canonical NF-kB pathway to enhance neutrophil recruitment and bacterial clearance [15]. In
MRSA-induced pneumonia model, NLRP6 KO mice had higher neutrophil accumulation in the
lungs due to reduced necroptosis and pyroptosis [12]. In both models, higher neutrophil
recruitment was found to be important to clear bacteria. However, in our polymicrobial sepsis
model, NLRP6 KO mice had reduced neutrophil recruitment, attenuated cytokine storm, and
higher survival. In support of our findings, higher neutrophil recruitment along with excessive
cytokine storm have been shown to worsen the outcome of sepsis [21, 39, 40]. In contrast to our
finding, NLRP6 was found important to clear Citrobacter rodentium [16] and
encephalomyocarditis viral infection from the intestine [17] suggesting that NLRP6 is important
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to clear enteric pathogens. These observations suggest that the role of NLRP6 could be site or
organ specific. In localized infection model such as intestinal inflammation, NLRP6 could play
crucial role; however, in case of septic model, NLRP6-induced inflammation is detrimental. This
spatiotemporal response of NLRP6 has made this NLR unique among its family members.
Different studies have reported that NLPR6 inflammasome regulates gut microbiota
composition and such differences in microbiota composition render the mice susceptible to
colitis and tumorigenesis [14-16, 18]. However, recent studies have challenged these observation
stating that NLRP6 inflammasome do not shape the microbiota composition [41, 42]. Although
NLRP6 inflammasome regulating the microbiota composition is debatable, we confirmed that
the resistant phenotype observed in the NLRP6 KO mice is not dependent on their microbiota
composition. The co-housed KO mice displayed similar phenotype as that of singly housed KO
mice confirming that NLRP6 regulate sepsis independent of microbiota composition (Figs 2F2H). Consistent with our findings, NLRP6 has been shown to regulate host defense against
microbial infections independent of microbiota composition [12, 15].
Loss of lymphocytes, particularly through apoptosis and inflammatory modes of cell
death is a hallmark of sepsis-induced immunosuppression [23, 43, 44]. Here we have shown that
NLRP6 inflammasome leads to loss of lymphocytes via reducing their proliferation and
enhancing both inflammatory and non-inflammatory modes of cell death. Additionally, we found
that NLRP6-driven IL-18 enhances sepsis-induced cell death ultimately leading to loss of
lymphocytes, particularly CD8 T cells which were found to be crucial for host defense.
However, IL-18 did not affect CD4 T cells population suggesting that reduced CD4 T cells
observed in WT mice could be due to reduced proliferation and non-IL-18-mediated cell death.
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Consistent with our findings, IL-18 has been shown to play detrimental roles in septic conditions
[26-28, 45] including pneumonia [46].
IFN-γ has been shown to enhance antigen presenting capacity of septic monocytes
through enhancing HLA-DR expression [32]. In addition, IFN-γ also enhances intracellular
killing ability of phagocytic cells [12]. These observations suggest that IFN-γ plays essential role
during sepsis. One of the hallmarks of immunosuppression in sepsis is reduced capacity of
lymphocytes to produce IFN-γ [34]. However, the exact mechanism behind this phenomenon is
not understood. In our study, we found that NLRP6 suppressed IFN-γ production by CD4 and
CD8 T cells. Consistent with these findings, increased IFN-γ production in NLRP6 KO mice was
reported during Gram-positive pneumonia [12]. However, the mechanisms underlying this
observation was not clear. Here we have demonstrated that NLRP6 reduces IFN-γ production by
suppressing T-bet expression in these cells. However, further research is needed to understand in
detail how NLRP6 interacts and suppresses T-bet expression in these cells. IL-18 has been
shown to enhance IFN-γ production by T cells [47]. However, in our model, NLRP6 KO mice
had higher IFN-γ production despite less IL-18. This result suggests that IFN-γ production in
NLRP6 KO mice is IL-18 independent. Since IFN-γ was higher in NLRP6 KO compared to the
WT mice, it is possible that this increased IFN-γ could further enhance the functions of
neutrophils and monocytes in these mice which ultimately leads to better bacterial clearance
observed in these mice.
Taken together, the current study discloses an unrecognized role of NLRP6
inflammasome during septic condition. Using appropriate human and mouse samples, we have
demonstrated that NLRP6 is upregulated in different cell types during sepsis and negatively
regulates host protection mechanism through modulating lymphocyte survival and function.
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Based on these results we purpose that blocking NLRP6 or it’s downstream cytokine, IL-18
could be an effective therapy to reduce sepsis-related mortality.
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CHAPTER 4. NEUTROPHIL HOMEOSTASIS DURING GRAM-POSITIVE
BACTERIAL PNEUMONIA
4.1 Introduction
Multiple studies using mouse models have demonstrated that neutrophils are essential for
containing Gram-positive bacterial pneumonia-induced sepsis including Streptococcus
pneumoniae (1) and S. aureus (2, 3). However, excessive neutrophil recruitment could be
hazardous to the host as these cells secrete enzymes and inflammatory mediators that can
damage tissues (4-6). Therefore, tight control of neutrophil homeostasis is important to contain
infections while causing minimum damage to the host. Since neutrophils have a short lifespan
(7), they are constantly generated in the bone marrow by granulopoiesis and released into the
circulation through a highly regulated process. In humans, 1 x 1011 neutrophils are mobilized
from the bone marrow every day as a part of steady-state granulopoiesis (8). During infection a
dramatic increase in bone marrow hematopoiesis is observed, called emergency granulopoiesis,
together with increased release of neutrophils from the bone marrow into the circulation to
contain the infection (9). However, the mechanism how granulopoiesis and neutrophil trafficking
is regulated during S. aureus infection remains elusive.
Staphylococcus aureus remains one of the major causes of acute pneumonia, skin
infection, and post-influenza superinfection (10-13). To date, antibiotics are the only therapeutic
option to treat S. aureus-induced pneumonia; however, their efficacy has been jeopardized by the
emergence of multiple antibiotic-resistant and hypervirulent strains such as methicillin-resistant
Staphylococcus aureus (MRSA). In this regard, optimal neutrophil accumulation into the lung is
a critical event for host defense and is a multi-step process that includes granulopoiesis, their
mobilization from bone marrow, and recruitment to the lungs. These processes rely on the
functions of chemokine ligands, their receptors, and different transcription factors (14-18).
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Specifically, CXC-chemokines such as CXCL1/Keratinocyte-derived chemoattractant (KC),
CXCL2/Monocyte inhibitory protein-2 (MIP-2), and CXCL5/Lipopolysaccharides-induced
CXC-chemokine (LIX) have been reported to mediate neutrophil recruitment during acute lung
injury via their common receptor, CXCR2 (19-22). CXCL5 is different from other CXCchemokines because it is chiefly secreted by type-II alveolar epithelial cells whereas other
chemokines, such as CXCL1 and CXCL2, are predominantly secreted by myeloid cells. We and
others have reported important roles of CXCL1, CXCL2, and MCP-1 in murine models of
pneumonia (21, 23-27). Human CXCL5 (also called epithelial cell-derived neutrophil-activating
peptide-78, ENA-78) has been implicated in various disease conditions such as COPD (28),
asthma (29), and acute coronary syndromes (30). CXCL5 has been reported to drive neutrophil
recruitment during murine models of LPS-induced lung inflammation (22), M. tuberculosis (31),
and crescentic glomerulonephritis (32). However, using an E coli-induced pneumonia model,
CXCL5 was found to suppress neutrophil recruitment and subsequent host defense (33)
suggesting that the function of CXCL5 could be model or pathogen specific. Nonetheless, the
role of CXCL5 in host defense against Gram-positive pneumonia-induced sepsis, including S.
aureus, remains unknown.
Under steady state conditions, CXCL5 has been shown to regulate neutrophil trafficking
along with GCSF (34). However, its role in a clinically relevant pathogen-induced emergency
granulopoiesis and neutrophil mobilization remains elusive. In this study we reveal previously
unrecognized roles of CXCL5 in a murine model of Gram-positive pneumonia-induced sepsis,
including in host defense, emergency granulopoiesis, and neutrophil mobilization. Using CXCL5
knockout (KO) mice, we found that CXCL5 attenuates neutrophil-mediated host defense by
suppressing IL-17A secretion by γδ T cells and neutrophils. In addition, our findings demonstrate

99

that CXCL5 suppresses S. aureus-induced emergency granulopoiesis via IL-17A and neutrophil
trafficking from the bone marrow through the IL-17A/CXCR2/CD62L signaling axis.
4.2 Methods
4.2.1 Mice. Eight-twelve-week-old female C57Bl/6 (Wild-type) and CXCL5 KO mice were used
throughout the experiments. WT mice were purchased from Jackson Laboratories (Bar Harbor,
ME) and CXCL5 KO mice were generated as described (33). Mice were kept in specific
pathogen-free housing with free access to food and water. Animal experiments were approved by
the Institutional Animal Care and Use Committee (IACUC) at Louisiana State University, Baton
Rouge.
4.2.2 Pneumonia-induced sepsis model. Age and sex-matched WT and CXCL5 KO mice were
anesthetized using ketamine (100 mg/kg) and xylazine (5 mg/kg) and then were infected with a
sublethal dose (5X107 CFU/mouse) of S. aureus intratracheally to induce pneumonia-induced
sepsis. For survival experiments, age-matched WT and CXCL5 KO mice were infected with 12X108 CFUs of S. aureus and survival observed for 150 hours. The mouse lung epithelial cell
lines (MLE12) were purchased from ATCC.
4.2.3 BALF collection and cell counting. BALF was collected as described in our previous
publication (3). Total and differential cell counting was performed in BALF using light
microscopy after Diff-quik staining.
4.2.4 Bone marrow chimera. Bone marrow chimeric mice were generated as reported in our
previous publication (3, 24). Briefly, recipient mice were subjected to a lethal dose of irradiation
(1000 rad) from a cesium source. RBC-free bone marrow cells from donor animals were injected
into the recipient animals through tail vein (8 million/mice) after irradiation. Four groups of
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chimeric mice were generated (WT→WT, KO→KO, WT→KO, KO→WT). These chimeric
mice were kept on 0.2% neomycin sulphate for 2 weeks. Eight weeks after transplantation,
chimeric mice were infected with S. aureus (5X107 CFU/mouse, i.t.). Mice were euthanized 24
hours post-infection to collect BALF for cytokine analysis.
4.2.5 Granulopoiesis. The granulopoiesis experiments were performed in accordance with
published guidelines (16, 17). Briefly, femurs and tibias obtained from control and infected WT
and CXCL5 KO mice were flushed with PBS (EDTA included) to obtain a single cell
suspension. After lysing RBCs, these cells were stained with fluorescently labelled antibodies
including live/dead aqua, Ly6G (IA8), c-Kit (2B8) (BioLegend), CD34 (RAM34, eBioscience),
and the cocktail of CD3ε (145-2C11), CD4 (GK1.5), CD8α (53-6.7), B220 (RA3-6B2), and
TER119 (Ter119) (BioLegend). For analyzing HSCs and myeloid progenitors, bone marrow
cells were stained with anti-FCRγIII/II (93), Sca-1 (D7), c-Kit (2B8), lineage cocktail (Lin-1)
(BioLegend), and CD34 (RAM34, eBioscience).
4.2.6 Antibodies and reagents. For blocking experiments, mice received 500ug of anti-Ly6G
antibody (BioXcell; clone IA8), or anti-IL-17A (BioXcell; clone 17F3) intraperitoneally (i.p.) at
12 and 2 hours prior to infection (3, 35). Mice received 150 µg of anti-CXCR2 or L-selectin
sheddase inhibitor (TAPI-O; Peptide internationals) i.p. at 0 and 12 hours post infection (27).
Control mice received PBS or dimethyl sulfoxide (DMSO) or isotype antibody as appropriate.
4.2.7 Flow cytometry and lung digestion. For flow cytometric analysis, RBC-free single cell
suspensions were made from bone marrow, blood, and lungs. These cells were treated with Fc
block prior to surface staining with the following antibodies for immunophenotyping: antiCD11b (M1/70), Ly6G (1A8), CD3 (145-2C11), CD4 (GK1.5), CD8α (53-6.7), and γδ-TCR
(UC7-13D5) (BioLegend). Appropriate isotype controls were used for each. The cells were fixed
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with 2% paraformaldehyde after staining and analyzed using either a FACs Caliber or
LSRFortessaX20 (BD). For intracellular staining, lungs obtained from S. aureus-infected WT
and KO were digested using collagenase IV (Worthington Biochemical Corporation, Lakewood,
NJ) and DNase I Recombinant (Sigma Aldrich, CA) by incubating in 37 0 C 5% CO2 incubation
for 90 minutes. The single cell suspension obtained after digestion was stimulated with leukocyte
activation cocktail containing Brefeldin A (BD Biosciences, San Jose, CA) for 4 hours at 37 0 C
5% CO2 prior to intracellular staining.
4.2.8 In vivo BrdU incorporation. BrdU incorporation experiment was performed in
accordance with the manufacturer’s recommendations (BD Biosciences). Briefly, WT and KO
mice were treated with BrdU (1mg/mouse, i.p.) immediately after infection with S. aureus. At
designated time points, mice were euthanized to collect bone marrow cells and stained with
fluorescently labelled antibodies including BrdU. The data were acquired using an
LSRFortessaX20 (BD).
4.2.9 Intracellular killing. The intracellular killing assay was performed as discussed in our
previous publication (3). Briefly, BMDNs obtained from WT and KO mice were pretreated with
either recombinant IL-17A (100 or 500 ng/ml) or vehicle control for 30 minutes prior to
infection with S. aureus (MOI of 10). At the indicated time points, extracellular bacteria were
killed using gentamicin. The cells were washed several times to remove excess gentamicin, lysed
with 0.1% triton-X to expose bacteria, serially diluted with PBS, and plated onto tryptic soy agar
to estimate intracellular bacterial loads.
4.2.10 ROS measurement. Total intracellular ROS produced from neutrophils was measured as
described previously (3, 36). Briefly, bone marrow-derived neutrophils (BMDNs) were isolated
from WT and KO mice through negative magnetic selection (STEMCELL technologies).
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BMDNs were then pretreated with either recombinant IL-17A (R & D System) (100 ng/ml and
500 ng/ml) or vehicle control for 30 minutes prior to infection with S. aureus (MOI:10). Onehour post-infection, ROS production was measured using a fluorometric kit (AA Bioquest).
4.2.11 Statistics. All statistical analyses were performed using GraphPad Prism 7.0 software.
All data are presented as mean ± SEM. Student t-test was used to compare means between two
groups. Whenever more than two groups were involved, ANOVA followed by Tukey’s multiple
comparison test was used. Survival data were analyzed using Log-rank (Mantel-cox) test.
Flowcytometric data were analyzed using FlowJo_V10 (Treestar). Significant differences are
indicated by * whenever p<0.05, ** p<0.01, *** p<0.001, and **** p<0.0001.
4.3 Results
4.3.1 CXCL5 deficiency enhances host protection during pulmonary S. aureus-induced
sepsis.
To investigate whether CXCL5 is upregulated in the blood and lungs following S.
aureus-induced pneumonia-derived sepsis, we first infected WT mice with S. aureus and
measured CXCL5 protein levels in these organs. CXCL5 was upregulated in blood and lungs
following infection with S. aureus (Fig. 4.1 A and B). Next, we sought to investigate the
signaling pathways essential for secretion of CXCL5 during MRSA infection. Since, TLRs have
been shown to enhance inflammatory cytokines production (37), we stimulated MLE12 cells
with different TLR agonists before infection with MRSA. Pretreatment with lipoteichoic acid
(TLR2), Pam3CSK (TLR1/2/4), and Pam2CSK (TLR2/6) significantly enhanced CXCL5
secretion suggesting that that TLRs signaling is important for CXCL5 secretion (Fig. 4.1C). In
line with the in vitro result, MyD88/Triff-/- also displayed reduced CXCL5 production (Fig.
4.1D). Since inflammasomes also regulate cytokine production (37), we used caspase 1/11-/- and
NLRP6-/- mice to determine if the secretion is inflammasome dependent. Interestingly, we found
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that CXCL5 production is reduced in these mice suggesting that inflammasomes regulates
MRSA-induced CXCL5 production (Fig. 4.1D). Further, to determine the signaling pathways
involved in secretion of CXCL5, we treated MLE12 cells with inhibitors of NF-κB, MAPK,
JNK, and p38 prior to infection with S. aureus. Inhibition of these pathways blocked the
production of CXCL5 indicating that these signaling pathways regulate CXCL5 production
during S. aureus infection (Fig. 4.1E).
Next, we sought to determine the role of CXCL5 in pulmonary S. aureus infection. To
this end, we infected WT and CXCL5 KO mice with a lethal dose of S. aureus (USA 300) and
observed survival for 150 hours. Compared to WT mice, CXCL5 KO mice had higher survival
rates (Fig. 4.1F). To determine whether the difference in survival is due to better clearance of
bacteria, we estimated bacterial burden in the lungs, BALF, and blood obtained from infected
WT and KO mice. Consistent with the survival data, KO mice demonstrated reduced bacterial
burden in these organs after infection (Fig. 4.1 G-I). To explore whether the phenotype displayed
by the KO mice is MRSA-specific, we infected WT and KO mice with similar dose of
methicillin-susceptible strain of S. aureus (MSSA, Newman strain). Consistent with MRSA
strain, KO mice displayed reduced bacteria in the lungs and BALF compared to that of WT mice
after infection with MSSA (Fig. 4.1 J and K). Taken together, these data suggest that CXCL5 is
detrimental to host survival during S. aureus-induced pneumonia.
To determine the cellular sources of CXCL5 during S. aureus infection, we generated
bone marrow chimeras between CXCL5 KO mice (KO) and WT mice (WT). Only WT recipient
mouse groups (WT→WT and KO→WT) showed measurable levels of CXCL5 in BALF after
infection with S. aureus. This indicates that primarily non-hematopoietic cells contribute to
CXCL5 secretion in the lung following pneumonia (Fig. 4.1 L).
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Figure 4.1. CXCL5 deficiency enhances host protection during S. aureus-induced pneumoniaderived sepsis. (A and B) CXCL5 levels in blood and BALF from S. aureus–infected (5X107
CFUs) WT mice (N=6-8/group) were measured using ELISA. (C) MLE12 cell lines were pretreated with TLR agonist such as Pam3CSK (500 ng/ml), Pam2CSK (500 ng/ml), lipoteichoic
acid (5 µg/ml), or PBS before infection with MRSA (MOI: 20). Ten hours post-infection,
CXCL5 was measured. (D) WT, MyD88/Triff-/-, Caspase 1/11-/- and NLRP6-/- mice (N=56/group) were infected with S. aureus. 24 hours post-infection, CXCL5 was measured in the
BALF fluid. (E) MLE12 cells were pre-treated with inhibitors of NF-κB, MAPK, JNK, and p38
(10µM each) for 4 hours and infected with S. aureus (MOI: 20). 10 hours post-infection, CXCL5
was measured. (F) WT and CXCL5 KO mice (N=12/group) were infected with 1-2X108 S.
aureus and survival was monitored for 150 hours. (G-I) Bacterial burden was measured in lungs
(G), BALF (H), and blood (I) of WT andCXCL5 KO mice (N=6-8/group) 24 hours postinfection with 5X107 CFUs of S. aureus (i.t.). (J and K) WT and CXCL5 KO mice (N=68/group) were infected with the Methicillin-susceptible strain of S. aureus (MSSA, Newmann
Strain) to induce pneumonia. Twenty-four hours post-infection, mice were euthanized to collect
BALF and lungs to measure bacterial burden. (L) Chimeric mice were generated as described in
Experimental Procedures. Eight weeks post-transplantation, the chimeric mice were infected
with S. aureus (5X107 CFUs/mouse). Twenty-four hours post-infection, mice were euthanized to
collect BALF. Levels of CXCL5 in cell-free BALF supernatants were measured using ELISA.
Data are presented as mean ± SEM. Each figure is a representative figure of 3 independent
experiments. * p<0.05; ** p<0.01; *** p<0.001; and **** p<0.0001.
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4.3.2 Neutrophils confer host protection in CXCL5 KO mice.
It is well established that neutrophils are critical for limiting Staphylococcal infections (2,
3, 38) . Therefore, we measured the extent of leukocyte accumulation in the alveolar space after
infection with S. aureus and found that CXCL5 KO mice had more accumulated neutrophils in
the BALF (Fig. 4.2 A and B). Similarly, the flow cytometric analysis of lungs tissue after
infection with S. aureus showed higher neutrophil recruitment in the lungs of CXCL5 KO mice
compared to that of WT mice (Fig. 4.2 C and D). To assess the role of neutrophils in host
protection, we depleted neutrophils and found that this reversed the survival advantage of
CXCL5 KO mice, indicating that the enhanced host protection observed in these mice is
neutrophil-dependent (Fig. 4.2 E).
4.3.3 γδ T cell- and neutrophil-derived IL-17A mediates neutrophil recruitment and
bacterial clearance in CXCL5 KO mice.
We next sought to determine the mechanism underlying the enhanced neutrophil influx in
CXCL5 KO mice. To this end, we analyzed cytokine and chemokine profiles in the BALF
following infection. To our surprise, KO mice had reduced CXCL1, MIP-2, TNF-α, IL-17F, and
IL-6 levels in BALF compared to the WT mice (Fig. 4.3A-F). In contrast, IL-17A was higher in
CXCL5 KO mice than in their WT counterparts (Fig. 4.4A). Because IL-17A has been shown to
mediate neutrophil recruitment to the lungs during bacterial infections (35, 39, 40), COPD (41),
and ischemia-reperfusion injury (42), we blocked IL-17A with an antibody in CXCL5 KO mice
and found attenuated neutrophil recruitment in the BALF (Fig. 4.4 B and C). Moreover, blocking
IL-17A also increased the bacterial burden in the lungs, BALF, and blood of CXCL5 KO mice
(Fig. 4.4 D-F), indicating that IL-17A is necessary for optimal bacterial clearance.
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Figure 4.2. Neutrophils confer host defense in CXCL5 KO mice. (A and B) WT and CXCL5 KO
mice (N=6-8/group) were infected with S. aureus (5X107 CFUs per mouse, i.t.) to induce
pneumonia. Twenty-four hours post-infection, mice were euthanized to collect BALF. Total and
differential counting were performed using light microscopy. (C) Lungs from S. aureus infected
WT and CXCL5 KO mice (N=5-7/group) were collected 24 hours post-infection to measure the
number of neutrophils recruited through flowcytometry. (D) Quantification of C. (E) Survival
following neutrophil depletion in CXCL5 KO mice. WT and KO mice (N=10/group) were either
treated with anti-Ly6G (IA8) or isotype control antibody at 24 and 2 hours prior to infection with
S. aureus (2X108 CFUs/mouse, i.t.). Survival was monitored for 150 hours. Data in the bar
diagrams are represented as Mean ± SEM and analyzed using two tailed unpaired student t-test.
Each figure is a representative of 3 independent experiments. The survival analysis was
performed using Log-rank (Mantel-cox) test. * p<0.05; ** p<0.01
107

Figure 4.3: CXCL5 regulates cytokines and chemokines during pulmonary S. aureus infection.
(A-F) WT and KO mice (N=6-8/group) were infected with S. aureus to induce pneumonia.
Twenty-four hours post infection, mice were euthanized to collect BALF. CXCL1 (A), MIP-2
(B), TNF-α (C), IL-6 (D), MCP-1 (E), and IL-17F (F) were measured in cell-free BALF
supernatants by ELISA. Each figure is representative of three independent experiments. Data are
presented as mean ± SEM. * p<0.05; ** p<0.01; *** p<0.001; and **** p<0.001.

In addition to neutrophil recruitment, we designed experiments to investigate whether IL17A modulates neutrophil function during S. aureus infection. Our findings show that
pretreatment of neutrophils with recombinant IL-17A significantly increases ROS production
(Fig. 4.4 G) and their intracellular killing ability during S. aureus infection (Fig. 4.4 H).
Collectively, these results suggest that IL-17A not only enhances neutrophil accumulation, but
also increases neutrophil function in CXCL5 KO mice during pulmonary S. aureus infection.
Since IL-17A production was higher in CXCL5 KO mice, we sought to determine the cellular
origin of this cytokine. To accomplish this, lungs from infected WT and KO mice were digested
to obtain single cell suspensions and then stained intracellularly with fluorescently labelled
antibodies to determine the source of IL-17A. Compared to WT mice, CXCL5 KO mice had
more IL-17A+ γδ T cells and neutrophils (Fig. 4.5 A-D), suggesting that these cells are the major
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sources of IL-17A production in KO mice during S. aureus infection. Furthermore, compared to
WT mice, CXCL5-deficient mice had increased numbers of γδ T cells (Fig. 4.5 E) in the lungs
after infection.

Figure 4.4. CXCL5 suppresses IL-17A production by γδ T cells and neutrophils during S. aureus
infection. (A-E) WT and KO mice (N=5-6/group) were infected with S. aureus (5X107 CFUs per
mouse, i.t.) or treated with PBS. Twenty-four hours post-infection, lungs were collected and
digested to obtain a single cell suspension. Cell were then re-stimulated with leukocyte activation
cocktail along with Brefeldin-A for 4 hours and processed for intracellular staining. IL-17Apositive γδ T cells (A and C) and neutrophils (B and D) were quantified. (E) Total γδ T cells per
250,000 events were calculated. Data presented as mean ± SEM. * p<0.05; ** p<0.01; ***
p<0.001.

4.3.4 CXCL5 deficiency increases emergency granulopoiesis during S. aureus-induced
acute pulmonary infection.
Since CXCL5 KO mice had augmented neutrophil accumulation in the lungs, we
explored whether CXCL5 deficiency could enhance emergency granulopoiesis or neutrophil
mobilization from the bone marrow during S. aureus pneumonia. Therefore, we assessed the
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total Ly6G-positive cells in the bone marrow after infection and found more neutrophils in the
bone marrow of CXCL5 KO mice than in WT mice (Fig. 4.6 A and B).

Figure 4.5: γδ T cell- and neutrophil-derived IL-17A mediates neutrophil-dependent host
immunity in CXCL5 KO mice. (A) IL-17A was measured in BALF obtained from S. aureusinfected WT and CXCL5 KO mice (24 hours post-infection). (B-F) WT and CXCL5 KO mice
(N=5-6/group) were treated with either anti-IL-17A or isotype control antibody 12 hours prior to
infection with S. aureus (5X107 CFUs per mouse, i.t.). Twenty-four hours post-infection, mice
were euthanized to collect blood, BALF, and lungs to measure leukocyte recruitment (B and C)
and bacterial burden (D-F). (G) BMDNs obtained from WT and CXCL5 KO mice were
pretreated with either recombinant mouse IL-17A (rIL-17A, 100 or 500 ng/ml) or vehicle control
for 30 minutes and then infected with S. aureus (MOI: 10). ROS production was measured using
a spectrophotometer. (H) BMDNs obtained from WT mice were treated with either rIL-17A (100
or 500 ng/ml) or vehicle control for 30 minutes prior to infection with S. aureus (MOI of 10). At
designated time points, intracellular killing ability was measured by estimating bacterial CFUs.
Each experiment was repeated thrice. Data represented as Mean ± SEM. * p<0.05; ** p<0.01;
*** p<0.001; and **** p<0.0001.
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Next, we used a novel flow cytometric method described by Satake et al (17) to analyze
different developmental stages of neutrophils within the bone marrow of WT and KO mice.
During development, granulocytes gradually loose C-kit expression and acquire Ly6G on their
surface and thus, early neutrophil precursors are C-kithighLy6G- (subpopulation #1) and mature
neutrophils are Ly6GhighC-kitlow (subpopulation #5) (Fig. 4.6 C). Compared to the controls, both
WT and CXCL5 KO mice had significant reductions in matured bone marrow neutrophils after
infection suggesting the release of neutrophils from bone marrow to the blood. However,
CXCL5 KO mice had significantly more mature neutrophils (subpopulation #5) in the bone
marrow compared to that of WT mice even after infection (Fig. 4.6 D and E). This increase in
bone marrow neutrophils in KO mice could either be due to increased granulopoiesis and/or
defective release to the blood. Therefore, we assessed Ly6G+ neutrophils in the blood after
infection and found that KO mice had significantly more neutrophils than WT counterparts (Fig.
4.6 F and G). This suggests more neutrophils were mobilized from the bone marrow in CXCL5
KO mice than in WT mice. Furthermore, we enumerated progenitor cells number in
subpopulation#1(C-kithighLy6G-) and found that the KO mice had more progenitor cells
compared to that of WT mice (Fig. 4.6 H). These results together indicate that the increased
number of mature neutrophils in the bone marrow of CXCL5 KO mice is due to increased
granulopoiesis and is not caused by defective release of neutrophils to the blood.
4.3.5 Deletion of CXCL5 augments S. aureus-induced amplification of early granulocyte
precursors.
It has been reported in previous studies that neutrophils are derived from hematopoietic
stem cells (HSCs) through common myeloid progenitors (CMPs) and granulocyte and
macrophage lineage restricted progenitor cells (GMPs) (16).
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Figure 4.6. CXCL5 deficiency increases emergency granulopoiesis following infection. WT and
CXCL5 KO mice (N=6-8/group) were infected with S. aureus (5X107 CFUs per mouse, i.t.) or
with PBS. Twenty-four hours post-infection, mice were euthanized to collect blood, bone
marrow, and lungs. (A and B) Bone marrow (BM) cells obtained from control and S. aureusinfected animals were stained with Ly6G antibody to assess the total neutrophil population
through flow cytometry. (C) Gating strategy to analyze different stages of neutrophils during S.
aureus-induced emergency granulopoiesis. Cells that lost the potential to differentiate into
neutrophils (cells expressing lineage markers for T and B cells, eosinophils, and erythroid cells)
were removed to identify the region 5 population (R5). Cells in R5 were gated for C-kit and
Ly6G markers and divided into five subpopulations based on C-kit and Ly6G expression.
Subpopulation #1 (C-kithighLy6G-), #2 (C-kitintLy6G-), and #5 (C-kitlowLy6Ghigh). (D and E) Flow
cytometric analysis of S. aureus-induced emergency granulopoiesis. Mature neutrophils
(subpopulation #5) from BM of WT and CXCL5 KO mice (control and infected) were
quantified. (F and G) Blood from control and S. aureus infected WT and CXCL5 KO mice were
collected and processed for flow cytometry to assess the total number of neutrophils. (H)
Numbers of cells in subpopulation #1 from Figure 4D were quantified. Data in the graphs are
represented as mean ± SEM. Each figure is a representative of three independent experiments. *
p<0.05; ** p<0.01; *** p<0.001.
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Figure 4.7. CXCL5 deficiency enhances S. aureus-induced amplification of early granulocyte
precursors. (A) BM cells obtained from WT and CXCL5 KO mice (control and S. aureus
infected) were subjected to flow cytometric analysis to investigate early progenitor cells.
Lineage-negative BM cells were analyzed. Numbers indicated on the flow cytometry plots are
the percentage among Lin- cells. (B and C) C-kit+Sca-1+lin- BM cells (hematopoietic stem cells,
HSCs) were quantified from (A). (D) C-kit+Sca-1-lin- BM cells were further analyzed to
enumerate different granulocyte precursor populations. Number within the gates shows the
percentage among C-kit+Sca-1-lin- BM cells. (E) Quantification of (D). (F) In vivo BrdU
incorporation. Numbers of BrdU-positive cells within each population of progenitor cells are
shown. Data are presented as mean ± SEM. Each figure is a representative of three independent
experiments. BM: bone marrow, HSC: hematopoietic stem cells, CMP: common myeloid
progenitors, GMP: granulocyte-macrophage progenitors, MEP: megakaryocyte-erythroid
progenitors, Con: control, SA: S. aureus * p<0.05; ** p<0.01.
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To determine the specific precursor population regulated by CXCL5, we analyzed Ckit+Sca-1+lin- HSCs and C-kit+Sca-1-lin- myeloid progenitor cells obtained from the bone
marrow of WT and CXCL5 KO mice after infection. Interestingly, KO mice had more HSCs
than WT mice (Fig. 4.7 A-C). Among myeloid progenitor cells, CXCL5 deficiency selectively
enhanced the population of GMP cells but not CMP (Fig. 4.7 D and E). However, the
megakaryocyte-erythroid progenitor (MEP) cells that give rise to thrombocytes and erythrocytes
were significantly reduced in the KO mice compared to that of WT counterparts (Fig. 4.7 D and
E). BrdU staining also demonstrated more BrdU+GMP cells in KO bone marrow than in WT
bone marrow after infection (Fig. 4.7 F). Together, these results suggest that genetic ablation of
CXCL5 enhances amplification of early granulocyte precursor cells during S. aureus-induced
emergency granulopoiesis.
4.3.6 IL-17A mediates both emergency granulopoiesis and neutrophil mobilization from
bone marrow in CXCL5 KO mice during infection.
Next, we sought to investigate the underlying mechanisms that led to increased
granulopoiesis and mobilization from the bone marrow in CXCL5 KO mice. Upregulation of IL17A via adenovirus-mediated delivery of murine IL-17A cDNA has previously been shown to
result in increased granulopoiesis under homeostatic conditions (43). Based on this observation
and the fact that IL-17A is higher in CXCL5 KO mice, we hypothesized that IL-17A could
mediate granulopoiesis and subsequent mobilization from the bone marrow during S. aureus
infection. To this end, we blocked IL-17A in CXCL5 KO mice using an antibody and observed
granulopoiesis after S. aureus infection. KO mice that received the blocking antibody showed
increased neutrophil numbers in the bone marrow compared to the group that received isotype
control antibody (Fig. 4.8 A and B).
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Figure 4.8. IL-17A regulates granulopoiesis and neutrophil mobilization from bone marrow in
CXCL5 KO mice following infection. WT and CXCK5 KO mice were treated with either antiIL17A or isotype control antibody prior to infection with S. aureus. Twenty-four hours postinfection, mice were euthanized to collect bone marrow and blood. Single cell suspensions
obtained from RBC-free bone marrow and blood were subjected to flowcytometric analysis. (A
and B) Bone marrow cells were stained to quantify total Ly6G positive cells. (C-E) BM cells
were stained to identify different stages of neutrophil maturation (C). Numbers of cells in
subpopulation #5 (D) and #1 (E) were quantified. (F and G) Neutrophils in the blood of WT and
CXCL5 KO mice were quantified. (H and I) C-kit+Sca-1-lin- BM cells were analyzed to compare
different progenitor cell populations. Cells within the GMP population were quantified. Data in
the graph is presented as the mean ± SEM. Each figure is representative of three independent
experiments. CMP: common myeloid progenitors, GMP: granulocyte-macrophage progenitors,
MEP: megakaryocyte-erythroid progenitors. * p<0.05; ** p<0.01; *** p<0.001.

Moreover, the number of cells in subpopulation #5 (mature neutrophils) increased in
CXCL5 KO mice treated with anti-IL-17A antibody compared to those receiving the isotype
control (Fig. 4.8 C and D). In contrast, cells in subpopulation #1 were significantly reduced after
blocking IL-17A in CXCL5 KO mice, but not in WT mice (Fig. 4.8 E). These results suggest
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that blocking IL-17A increases neutrophil retention and reduces granulopoiesis in the bone
marrow of KO mice. However, inhibition of IL-17A in WT mice led to increased retention of
neutrophils but did not affect the early progenitor cell population (Fig. 4.8D and E). To further
confirm this result, we measured neutrophils in the blood after blocking IL-17A and found
significantly fewer neutrophils in the blood of antibody receiving group (Fig. 4.8F and G)
compared to those given the isotype control. This neutrophil hyperplasia in bone marrow and
neutropenia in blood following antibody treatment confirms that IL-17A is required for
neutrophil mobilization from bone marrow during S. aureus infection. Similarly, to confirm that
IL-17A enhances granulopoiesis in CXCL5 KO mice, we further analyzed early granulocyte
precursor populations in these mice and found that IL-17A blockade caused a reduction in GMP
cells after infection (Fig. 4.8H and I). Taken together, these data indicate that IL-17A mediates
granulopoiesis as well as neutrophil trafficking from the bone marrow in CXCL5 KO mice
during pulmonary S. aureus-induced pneumonia.
4.3.7 CXCL5 regulates neutrophil mobilization via IL-17A/CXCR2/CD62L signaling axis.
The chemokine receptors CXCR2 and CXCR4 act antagonistically to regulate the release
of neutrophils from the bone marrow into circulation (44-47). Therefore, we investigated
whether CXCL5 regulates the expression of CXCR2 or CXCR4 during pulmonary S. aureus
infection. No difference between WT and KO mice was observed in case of CXCR4 expressing
neutrophils in the bone marrow (Fig.4.9A). However, higher number of CXCR2-expressing
neutrophils in bone marrow (Fig. 4.9B) and blood (Fig. 4.9C) of KO mice was observed
compared to that of WT mice indicating that the enhanced mobilization of neutrophils involves
CXCR2 signaling. To confirm this result, we blocked CXCR2 in the KO mice after infection and
observed increased retention of neutrophils in the bone marrow (Fig. 4.9D). Accordingly,
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neutrophil number in blood of antibody receiving group was reduced compared to isotype
antibody receiving mice (Fig. 4.9E). To further understand the involvement of the
CXCR2/CXCR4 axis, we assessed CXCR2+ and CXCR4+ neutrophils in the bone marrow and
blood of CXCL5 KO mice treated with IL-17A blocking antibody. The CXCR2+ neutrophil
population was significantly reduced in the blood of mice treated with blocking antibody (Fig.
4.9C); however, no significant changes were observed in the expression of CXCR4 in the bone
marrow following antibody treatment (Fig.4.9A).

Figure 4.9. IL-17A and CXCR2 signaling is critical for neutrophil mobilization in CXCL5 KO
mice. (A-C) WT and CXCL5 KO mice (N=6-8/group) were treated with either anti-IL-17A or
isotype control antibody prior to infection with S. aureus. Twenty-four hours post-infection,
mice were euthanized to collect bone marrow and blood for flow cytometric analysis of CXCR4
and CXCR2 on neutrophils. CXCR4 (A) and CXCR2 (B) positive neutrophils in the bone
marrow are shown. (C) CXCR2-positive neutrophils in the blood. (D and E) WT and CXCL5
KO mice (N=5-7 per group) were either treated with isotype antibody or anti-CXCR2 at 0- and
12-hours post-infection with S. aureus. Twenty-four hours post-infection, mice were euthanized
to collect bone marrow and blood. Total neutrophils in bone marrow (D) and blood (E) were
quantified using flowcytometry. Each figure is a representative figure of 3 independent
experiments. Data in the graph are represented as mean ± SEM. * p<0.05; ** p<0.01; ***
p<0.001.
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In addition to conventional CXCR4/CXCR2 axis, neutrophil trafficking from bone
marrow is also regulated by adhesion molecules such as selectins and integrins. During
mobilization from bone marrow in response to chemokine or infection, neutrophils shed selectins
(CD62L) and increase the expression of integrins (CD49d or CD18) on their surface (48, 49).
Therefore, we assessed whether neutrophil mobilization in response to S. aureus infection
involves changes in these adhesion molecules. No changes in the levels of β2 integrins
(CD11a/CD18) were found on the surface of neutrophils after MRSA infection (Figs. 4.10A-D).
Compared to the controls, neutrophils from infected groups displayed reduced CD62L and
elevated CD29d on their surface (Figs. 4.10E-H) suggesting that expression of these molecules
are altered during S. aureus infection. In addition, shedding of CD62L was higher in the KO
mice compared to their WT controls indicating that CXCL5 deficiency enhances CD62L
sheddase activity to augment neutrophil mobilization from bone marrow (Figs. 4.10E and F). To
confirm this result, we administered L-selectin sheddase inhibitor (TAPI-O) in both WT and KO
mice after infection and found that the inhibition was associated with enhanced retention of
neutrophils in bone marrow along with reduced neutrophil recruitment in the blood and lungs
(Figs. 4.10I-K). Taken together, these results suggest that neutrophil mobilization from bone
marrow into the blood and lungs in S. aureus-infected CXCL5 KO mice requires IL17A/CXCR2/CD62-L signaling axis. G-CSF has been shown to play an important role in both
steady-state and emergency granulopoiesis (50-53). Thus, we were interested to determine
whether CXCL5 regulates GCSF during pulmonary S. aureus infection. Compared to the
controls, both WT and CXCL5 KO mice had significantly more GCSF secreted in the bone
marrow, blood, and the BALF after infection, suggesting that GCSF is involved during S.
aureus-induced emergency granulopoiesis (Fig. 4.11 A-C).
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Figure 4.10: CXCL5 deficiency augments shedding of CD62L to enhance neutrophil trafficking
from bone marrow. WT and CXCL5 KO mice (N=5-7 per group) were infected with S. aureus to
induce pneumonia. Twenty-four hours post-infection, mice were euthanized to collect bone
marrow. The single cell suspension obtained from bone marrow were stained with florescent
antibodies to measure the expression levels of CD11a (A and B), CD18 (C and D), CD62L (E
and F) and CD49d (G and H). (I-K) WT and CXCL5 KO mice (N=5-6 per group) were either
treated with DMSO or L-selectin sheddase inhibitor (TAPI-O) at 0- and 12-hours post-infection
with S. aureus. Twenty-four hours post-infection, mice were euthanized to collect bone marrow,
blood, and the lungs. Total neutrophils in bone marrow (I), blood (J), and lungs (K) were
quantified using flowcytometry. Each figure is a representative figure of 3 independent
experiments. Data in the graph are represented as mean ± SEM. BM: bone marrow, DMSO:
dimethyl sulfoxide, TAPI-O: TNF-α protease inhibitor, MFI: mean florescence intensity. *
p<0.05; ** p<0.01; *** p<0.001.

Although, CXCL5 KO mice had increased granulopoiesis and neutrophil mobilization,
we did not find differences in the levels of GCSF in the bone marrow, blood, or BALF between
WT and CXCL5 KO mice after infection (Fig. 4.11 A-C). However, blocking of IL-17A
significantly reduced GCSF levels in bone marrow, serum, and BALF of KO mice, suggesting
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that GCSF works downstream of IL-17A for neutrophil mobilization from bone marrow (Fig.
4.11 A-C).

Figure 4.11: Levels of GCSF before and after infection with S. aureus. (A-C) WT and KO mice
(N=6-8/group) were treated with either isotype antibody or anti-IL-17A before infection with S.
aureus. Twenty-four hours post-infection, mice were euthanized to collect BALF, bone marrow,
and blood. GCSF in cell-free BALF supernatants, bone marrow, and serum were measured using
standard ELISA procedure. Each figure is a representative of three independent experiments.
Data are presented as mean ± SEM. * p<0.05 and *** p<0.001.

4.4 Discussion
Community-acquired MRSA (CA-MRSA) is endemic in US and remains a significant
cause of mortality and morbidity worldwide (11). Currently, the efficacy of antibiotics used to
treat this superbug-induced disease has been reduced due to increased resistance among bacterial
species along with a substantial increase in the number of immunocompromised patients. In this
context, understanding the host defense mechanism against Gram-positive bacteria could help
inform the design of effective host-targeted therapeutics to treat such infections.
Neutrophils are a crucial component of the innate immune defense mechanism that
respond quickly during bacterial pneumonia by migrating into the lungs. This migration is
directed by chemokines of which, CXCL5 (or ENA-78) has been strongly correlated with
neutrophil recruitment to the lungs of patients with acute respiratory distress syndrome (54). In
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mice, Cxcl5 was initially identified as a glucocorticoid-attenuated response gene (55), and has
since been shown to mediate neutrophil recruitment in a rat model of ischemia-reperfusion injury
(56) and during LPS-induced lung inflammation (22, 57). In this study, we illustrated the
signaling mechanism regulating CXCL5 secretion during S. aureus infection. We found that
TLRs and NF-κB/MAKP pathways are essential for CXCL5 section. Furthermore, we unveiled
an unexpected role of CXCL5 where CXCL5 suppressed neutrophil influx into the lungs, thereby
hindering staphylococcal clearance. A similar negative function of CXCL5 in neutrophil
recruitment was reported in Gram-negative E. coli-induced pneumonia model (33). In contrast,
CXCL5 was found to be important for neutrophil recruitment in models of M. tuberculosis
infection (31) and crescentic glomerulonephritis (32). This recruitment, however, was shown to
increase pulmonary inflammation and renal tissue injury, respectively. These disparities in
neutrophil functions and the role of CXCL5 in neutrophil recruitment could be explained by the
differences in models and pathogens used in these studies.
Using a well-established flow cytometric technique (16, 17), we report that S. aureus
exploits CXCL5 to suppress emergency granulopoiesis and neutrophil mobilization from bone
marrow. This is evident from the fact that CXCL5 deficiency selectively increased the
proliferation of HSCs and C-kit+Sca-1-lin- GMP cells within the granulocyte progenitor
compartments and enhanced the trafficking of mature neutrophils from bone marrow. The
increased neutrophil recruitment in the lungs of CXCL5 KO mice is a net result of both increased
granulopoiesis and augmented release into the circulation. Our data further revealed that IL-17A
mediates granulopoiesis and neutrophil trafficking into the blood and lungs of CXCL5 KO mice
ultimately leading to increased neutrophil recruitment and enhanced bacterial clearance. Various
cell types, including γδ T cells, Th-17 cells, NK cells, and neutrophils, can secrete IL-17A (34).
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In the model employed in the current study, γδ T cells and neutrophils are major sources of IL17A secretion, which is in agreement with earlier findings of Staphylococcal infection (58-60).
As reported in different studies (35, 59, 60), we suggest that γδ T cells are the early source of IL17A production that drives initial neutrophil recruitment to the lungs. At later time points, these
recruited neutrophils contribute for more IL-17A production. We further suggest that increased
amount of IL-17A in CXCL5 KO mice could be due to increased numbers of γδ T cells and
neutrophils recruited in the lungs during infection. Further research is needed to understand in
detail how CXCL5 could suppress IL-17A production during S. aureus-induced pneumonia.
The CXC-chemokines CXCL1, CXCL2, and CXCL5 bind to their common receptor,
CXCR2, and are thought to have redundant roles in neutrophil homeostasis. Multiple studies
have demonstrated that CXCR2 and CXCR4 reciprocally regulate neutrophil mobilization from
bone marrow into the circulation (44, 45). Studies have further shown that disruption of CXCR2
leads to retention of neutrophils in the bone marrow while disruption of CXCR4 causes increased
mobilization into the circulation (45, 61). In accordance with these observations, we found
increased CXCR2-expressing neutrophils in the bone marrow of CXCL5 KO mice, which
correlated with higher neutrophil mobilization in these mice. Blocking of IL-17A led to
reduction in numbers of CXCR2-expressing neutrophils in the blood but no change was observed
in neutrophil that expressed CXCR4 in the bone marrow indicating that CXCR2 plays critical
role for trafficking of neutrophils in our model. Essential role of CXCR2 in neutrophil trafficking
has been shown in other model of studies too (45, 46). Several cell adhesion molecules are
involved in neutrophil mobilization from bone marrow during homeostatic and infectious
conditions (48, 49). However, we only observed alteration in the expression levels of CD62L and
CD49d during S. aureus-induced pneumonia-derived sepsis suggesting that S. aureus specifically
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modulates these molecules during infection. Furthermore, CXCL5 KO mice had altered
expression of CD62L compared to that of WT mice. In addition, blocking of L-selectin sheddase
activity impeded the trafficking of neutrophils from bone marrow to the blood and lungs. These
observations together suggest that CXCL5 deficiency enhanced neutrophil trafficking via IL17A, CXCR2, and CD62L signaling axis. In normal condition, CXCL5 mediated neutrophil
homeostasis requires GCSF signaling (34). However, in our model of S. aureus-induced
pneumonia, CXCL5 did not affect GCSF levels in the bone marrow, blood, or the lungs
suggesting that CXCL5 could regulate emergency granulopoiesis independent of GCSF
signaling.
Several studies have reported the involvement of IL-17A in mediating neutrophil
recruitment to the lungs during infections (24, 39, 41, 42). However, since IL-17A itself is not an
established chemokine, the mechanism underlying IL-17A mediated neutrophil recruitment
during infection remained elusive. Although the involvement of IL-17A in steady-state
granulopoiesis has been reported from several studies (34, 43, 62), the importance of this
cytokine in pathogen-induced emergency granulopoiesis has yet remained unexplored. By using
S. aureus induced-pneumonia model, we demonstrate for the first time that IL-17A enhances
emergency granulopoiesis and augments neutrophil mobilization via CXCR2 and CD62L to
enhance neutrophil accumulation in the lungs during infection.
In conclusion, this is a pioneer study to report the detail mechanism of neutrophil
homeostasis during S. aureus-induced pneumonia-derived sepsis. Our findings illustrate that
CXCL5 orchestrates MRSA-induced granulopoiesis via IL-17A and subsequent mobilization of
neutrophils into the lungs via IL-17A/CXCR2/CD62L axis. Particularly, previous studies on
other members of CXC-chemokines, especially CXCL1 and CXCL2, have reported essential
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roles of these chemokines for host defense as well as neutrophil homeostasis (25, 27, 48, 63). In
contrast, our study has pointed out opposite roles of CXCL5 in both neutrophil homeostasis and
host defense in response to S. aureus infection. Based on this observation, we propose that within
the CXC-chemokine family, CXCL5 could act as a negative regulator of neutrophil-mediated
host defense to prevent overt pathology during microbial infection. Nonetheless, we have
unveiled a previously unrecognized role of CXCL5 in S. aureus-induced pneumonia and
subsequent emergency granulopoiesis and blocking of CXCL5 could be a promising therapeutic
strategy to enhance bacterial clearance in patients with Gram-positive pneumonia-derived sepsis.
Moreover, upregulation of CXCL5 could be a novel immune modulation strategy of S. aureus to
evade neutrophil-mediated host defense in the lungs.
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CHAPTER 5. CONCLUSIONS AND FUTURE PERSPECTIVES
5.1 Introduction
Nod-like receptors (NLRs) are germline encoded intracytoplasmic pattern recognition
receptors that sense danger signals including pathogen-associated molecular patterns (PAMPs)
and damage-associated molecular patterns (DAMPs) [1, 2]. Although 23 NLRs have been
identified in humans and more than 30 in the mice, only a few of them have been studied
extensively. NLRP6 was identified to activate caspase 1 in human cell lines [3] but the signaling
mechanism remained elusive. While the roles of NRLP6 in regulation of the intestinal microbiota
were widely studied, its role in the host defense in the context of acute lung injury and sepsis
largely remained unknown. In this dissertation, we have used the mouse model of MRSAinduced pneumonia and cecal ligation and puncture (CLP)-induced polymicrobial sepsis to
delineate the roles of NLRP6 in host defense mechanism during acute lung injury and sepsis
respectively. In chapter 1, we introduced NLRP6 and discussed the recent advancements in its
signaling mechanism, the host defense during pathogenic insults, and regulation of microbiota by
this receptor (review manuscript currently under revision in Mucosal Immunology). In chapter 2,
we investigated the role of NLRP6 in pulmonary host defense during Gram-positive bacterial
infection (published in PLoS Pathogens). Chapter 3 describes the role of NLRP6 in
polymicrobial sepsis (manuscript to be submitted), and chapter 4 demonstrates how MRSA
regulate neutrophil homeostasis to evade host immunity (under revision in Proceedings of
National Academy of Sciences). We used MRSA as a model bacterium to investigate the host
defense mechanism in pneumonia because MRSA is the leading cause of pneumonia in healthcare settings. The summary of each chapter along with implication of results have been discussed
below.
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5.2 Discussion of results
In chapter 2, we elucidated the roles of NLRP6 inflammasome in pulmonary host defense
during Gram-positive pneumonia. By using the mouse model of MRSA-induced acute lung
injury model, we demonstrated for the first time that the NLRP6 is activated during Grampositive bacterial infection in the lungs [4]. NLRP6 expression was increased in neutrophils,
macrophages, and epithelial cells of pneumonic patients as well as in MRSA-infected mice. We
found that NLRP6 is detrimental to host survival as NLRP6-/- mice displayed enhanced survival
and reduced bacterial burden in lungs and extra-pulmonary organs. Further, we have shown that
NLRP6-/- mice accumulate more neutrophils in the lungs that are essential to limit MRSA
infection. The augmented neutrophil accumulation in the lungs was not chemokine-dependent as
NLRP6-/- mice displayed less chemokines compared to that of WT mice. Using in vivo and in
vitro techniques, we found that NLRP6 triggers necroptosis and pyroptosis in the lungs that
deplete macrophages and neutrophils. Blocking necroptosis and pyroptosis using specific
inhibitors enhanced the survival in WT mice suggesting that NLRP6 induces detrimental effects
via triggering inflammatory modes of cell death. In addition, NLRP6 also enhanced killing
ability of neutrophils via augmenting NADPH-oxidase-mediated ROS production. NLRP6 was
found to negatively regulate host immunity during systemic bacterial infection [5]; however, the
mechanism was not clear. Through this study we showed that NLRP6 is detrimental during
MRSA infection and delineated the mechanism by which NLRP6 drives detrimental effects. We
believe that the results of chapter 2 will help to fill the knowledge gap and provide significant
advancement regarding the role of NLRP6 in host defense during microbial infection.
The chapter 3 delineates the role of NLRP6 in sepsis by using the murine model of
polymicrobial sepsis. Sepsis is a life-threatening medical condition caused by bacteria leading to
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multiple vital organ’s dysfunction and death. Despite continuous research, the detailed
pathophysiology of sepsis is still elusive. Sepsis is characterized by an early hyperinflammatory
condition followed by a delayed immunosuppressive stage [6-8]. However, how these two
phases are developed in septic patients and how they contribute to mortality is not clear. Using
the mouse model of CLP-induced polymicrobial sepsis, we demonstrated that NLRP6 elicits
hyperinflammation and lymphocyte loss during the septic condition. We have shown that
NLRP6 is upregulated in splenic T cells in human septic patients and CLP-induced septic mice.
Based on this, we hypothesized that NLRP6 regulates immunity during sepsis. NLRP6-/- mice
were resistant to polymicrobial sepsis as evident by increased survival and reduced bacterial
burden in these mice. Further investigating the mechanism, we found that NLRP6 elicits
destructive inflammation via IL-18 as the addition of recombinant IL-18 to these mice reduced
inflammation and enhanced the survival. Moreover, T cells from NLRP6-/- mice produced more
IFN-γ as a result of higher expression of transcription factor T-bet. Finally, blocking IL-18 in
WT mice reduced cell death, inflammation, and mortality during polymicrobial sepsis. IL-18 was
found to be detrimental in different murine septic models [9, 10]; however, how IL-18 exerts
detrimental effects was not known. The results of the chapter 3 demonstrate that NLRP6-derived
IL-18 increases susceptibility to polymicrobial sepsis via exaggerating inflammation and cell
death. These results have clinical implications as excessive lymphocyte loss is one of the causes
of mortality in septic patients.
In chapter 4, we demonstrate how neutrophil homeostasis is regulated during MRSAinduced pneumonia-derived septic condition. Neutrophil accumulation in the lungs is a critical
step that involves neutrophil production in bone marrow (granulopoiesis), their mobilization into
the blood, and recruitment to the lungs. Since neutrophils are essential to limit MRSA infection,
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it is important to study how neutrophil homeostasis is regulated during MRSA infection. Using
well-designed flow cytometric technique, we demonstrate that MRSA regulates CXCL5 to
suppress emergency granulopoiesis. CXCL5 was found to dampen granulopoiesis via
suppressing the numbers of hematopoietic progenitor cell population in the bone marrow. As a
result, neutrophil numbers were inadequate in the lungs to combat the infection. In addition, a
compensatory increase in IL-17A in the absence of CXCL5 was found to enhance granulopoiesis
and neutrophil mobilization from bone marrow. Our data further indicated that CXCL5 regulates
CXCR2, CD62L, and CD49d to suppress the neutrophil release from bone marrow. Together,
these data indicate that MRSA exploits CXCL5 as a part of its immune evasion strategy to
dampen neutrophil number in the lungs.
5.3 Conclusions and future directions
While chapters 2 and 3 demonstrate how NLRP6 enhances susceptibility to sepsis derived from
pulmonary MRSA infection and CLP-induced peritonitis respectively, chapter 4 delineates the
mechanisms by which neutrophil homeostasis is regulated during pulmonary MRSA infection.
The research findings described in this body of work has advanced the field of NLRP6
inflammasome considerably by establishing its role in host defense against bacterial infections
and septic peritonitis. However, understanding of the big picture of MRSA pneumonia and septic
peritonitis is far from complete, and these additions to the field of host-pathogen interaction will
provide a platform for future research into the pathogenesis of pulmonary MRSA infection and
CLP-induced peritonitis. Continued research should focus on understanding (1) the molecular
mechanism of how NLRP6 triggers necroptosis, and (2) whether NLRP6 itself interact with
MLKL and RIP3 or induces necrosome assembly via indirect mechanisms. Another avenue is to
characterize if NLRP6 exerts detrimental or beneficial effect in fungal and Gram-negative
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bacterial pneumonia as each pathogen has its own virulence factors and immune evading or
stimulating strategies. Since NLRP6 regulates CXCL5 secretion, the other avenue is to determine
if NLRP6 has any direct effect on granulopoiesis and neutrophil release from bone marrow.
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